UNITED STATES	OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB Number: 3235-0582 Expires: May 31, 2021 Estimated average burden hours per response........7.2

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number  811- 06565

Tekla World Healthcare Fund

(Exact name of registrant as specified in charter)

100 Federal Street, 19th Floor, Boston, MA	02110
(Address of principal executive offices)	(Zip code)

Laura Woodward

Tekla World Healthcare Fund

100 Federal Street, 19^th Floor, Boston MA 02110

(Name and address of agent for service)

Registrant’s telephone number, including area code:  617-772-8500

Date of fiscal year end:  September 30

Date of reporting period:  7/1/19-6/30/20

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

Item 1. Proxy Voting Record.

THW Vote Summary 

ABBOTT LABORATORIES
Security	002824100	Meeting Type	Annual
Ticker Symbol	ABT	Meeting Date	24-Apr-2020
Record Date	26-Feb-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	R.J. Alpern		For	For
		2	R.S. Austin		For	For
		3	S.E. Blount		For	For
		4	R.B. Ford		For	For
		5	M.A. Kumbier		For	For
		6	E.M. Liddy		For	For
		7	D.W. McDew		For	For
		8	N. McKinstry		For	For
		9	P.N. Novakovic		For	For
		10	W.A. Osborn		For	For
		11	D.J. Starks		For	For
		12	J.G. Stratton		For	For
		13	G.F. Tilton		For	For
		14	M.D. White		For	For
2.	Ratification of Ernst & Young LLP as Auditors.			Management	For	For
3.	Say on Pay - An Advisory Vote to Approve Executive Compensation.			Management	For	For
4.	Shareholder Proposal - Lobbying Disclosure.			Shareholder	Against	For
5.	Shareholder Proposal - Non-GAAP Financial Performance Metrics Disclosure.			Shareholder	Against	For
6.	Shareholder Proposal - Shareholder Voting on By-Law Amendments.			Shareholder	Against	For
7.	Shareholder Proposal - Simple Majority Vote.			Shareholder	Against	For

ABBVIE INC.
Security	00287Y109	Meeting Type	Annual
Ticker Symbol	ABBV	Meeting Date	08-May-2020
Record Date	13-Mar-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Robert J. Alpern		For	For
		2	Edward M. Liddy		For	For
		3	Melody B. Meyer		For	For
		4	Frederick H. Waddell		For	For
2.	Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2020			Management	For	For
3.	Say on Pay - An advisory vote on the approval of executive compensation			Management	For	For
4.	Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting			Management	For	For
5.	Stockholder Proposal - to Issue an Annual Report on Lobbying			Shareholder	Against	For
6.	Stockholder Proposal - to Adopt a Policy to Require Independent Chairman			Shareholder	For	Against
7.	Stockholder Proposal - to Issue a Compensation Committee Report on Drug Pricing			Shareholder	Against	For

ABIOMED, INC.
Security	003654100	Meeting Type	Annual
Ticker Symbol	ABMD	Meeting Date	07-Aug-2019
Record Date	10-Jun-2019

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Michael R. Minogue		For	For
		2	Martin P. Sutter		For	For
2.	Approval, by non-binding advisory vote, of the compensation of our named executive officers.			Management	For	For
3.	Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2020.			Management	For	For

ACADIA HEALTHCARE COMPANY, INC.
Security	00404A109	Meeting Type	Annual
Ticker Symbol	ACHC	Meeting Date	07-May-2020
Record Date	12-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Wade D. Miquelon	Management	For	For
1B.	Election of Director: William M. Petrie, M.D.	Management	For	For
2.	Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement.	Management	For	For
3.	Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For

AGILENT TECHNOLOGIES, INC.
Security	00846U101	Meeting Type	Annual
Ticker Symbol	A	Meeting Date	17-Apr-2020
Record Date	22-Jan-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director for a three-year term: Heidi Kunz	Management	For	For
1.2	Election of Director for a three-year term: Sue H. Rataj	Management	For	For
1.3	Election of Director for a three-year term: George A. Scangos, Ph.D.	Management	For	For
1.4	Election of Director for a three-year term: Dow R. Wilson	Management	For	For
2.	To approve the Agilent Technologies, Inc. 2020 Employee Stock Purchase Plan.	Management	For	For
3.	To approve, on a non-binding advisory basis, the compensation of Agilent's named executive officers.	Management	For	For
4.	To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as Agilent's independent registered public accounting firm.	Management	For	For

ALCON INC.
Security	H01301128	Meeting Type	Annual
Ticker Symbol	ALC	Meeting Date	06-May-2020
Record Date	23-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the operating and financial review of Alcon Inc., the annual financial statements of Alcon Inc. and the consolidated financial statements for 2019	Management	For	For
2.	Discharge of the Members of the Board of Directors and the Members of the Executive Committee	Management	For	For
3.	Appropriation of earnings as per the balance sheet of Alcon Inc. of December 31, 2019.	Management	For	For
4A.	Consultative vote on the 2019 Compensation Report	Management	For	For
4B.	Binding vote on the maximum aggregate amount of compensation of the Board of Directors for the next term of office, i.e. from the 2020 Annual General Meeting to the 2021 Annual General Meeting	Management	For	For
4C.	Binding vote on the maximum aggregate amount of compensation of the Executive Committee for the following financial year, i.e. 2021	Management	For	For
5A.	Re-election of Director: F. Michael Ball (as Member and Chairman)	Management	For	For
5B.	Re-election of Director: Lynn D. Bleil (as Member)	Management	For	For
5C.	Re-election of Director: Arthur Cummings (as Member)	Management	For	For
5D.	Re-election of Director: David J. Endicott (as Member)	Management	For	For
5E.	Re-election of Director: Thomas Glanzmann (as Member)	Management	For	For
5F.	Re-election of Director: D. Keith Grossman (as Member)	Management	For	For
5G.	Re-election of Director: Scott Maw (as Member)	Management	For	For
5H.	Re-election of Director: Karen May (as Member)	Management	For	For
5I.	Re-election of Director: Ines Pöschel (as Member)	Management	For	For
5J.	Re-election of Director: Dieter Spälti (as Member)	Management	For	For
6A.	Re-election of the Member of the Compensation Committee: Thomas Glanzmann	Management	For	For
6B.	Re-election of the Member of the Compensation Committee: D. Keith Grossman	Management	For	For
6C.	Re-election of the Member of the Compensation Committee: Karen May	Management	For	For
6D.	Re-election of the Member of the Compensation Committee: Ines Pöschel	Management	For	For
7.	Re-election of the independent representative, Hartmann Dreyer Attorneys-at-law	Management	For	For
8.	Re-election of the statutory auditors, PricewaterhouseCoopers SA, Geneva	Management	For	For
9.	Note: General instruction in case of new agenda items or proposals during the Annual General Meeting (please check one box only). * If you vote FOR, you will be voting in accordance with the recommendation of the Board of Directors. ** If you vote ABSTAIN, you will ABSTAIN from voting.	Management	Abstain

ALEXION PHARMACEUTICALS, INC.
Security	015351109	Meeting Type	Annual
Ticker Symbol	ALXN	Meeting Date	13-May-2020
Record Date	16-Mar-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Felix J. Baker		For	For
		2	David R. Brennan		For	For
		3	Christopher J. Coughlin		For	For
		4	Deborah Dunsire		For	For
		5	Paul A. Friedman		For	For
		6	Ludwig N. Hantson		For	For
		7	John T. Mollen		For	For
		8	Francois Nader		For	For
		9	Judith A. Reinsdorf		For	For
		10	Andreas Rummelt		For	For
2.	Proposal No. 2 - Ratification of appointment by the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.			Management	For	For
3.	Proposal No. 3 - Approval of a non-binding advisory vote of the 2019 compensation paid to Alexion's named executive officers.			Management	For	For
4.	Proposal No. 4 - Shareholder proposal requesting certain By-law amendments to lower the threshold for shareholders to call a special meeting.			Shareholder	Against	For

ALIGN TECHNOLOGY, INC.
Security	016255101	Meeting Type	Annual
Ticker Symbol	ALGN	Meeting Date	20-May-2020
Record Date	25-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kevin J. Dallas	Management	For	For
1B.	Election of Director: Joseph M. Hogan	Management	For	For
1C.	Election of Director: Joseph Lacob	Management	For	For
1D.	Election of Director: C. Raymond Larkin, Jr.	Management	For	For
1E.	Election of Director: George J. Morrow	Management	For	For
1F.	Election of Director: Anne M. Myong	Management	For	For
1G.	Election of Director: Thomas M. Prescott	Management	For	For
1H.	Election of Director: Andrea L. Saia	Management	For	For
1I.	Election of Director: Greg J. Santora	Management	For	For
1J.	Election of Director: Susan E. Siegel	Management	For	For
1K.	Election of Director: Warren S. Thaler	Management	For	For
2.	RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2020.	Management	For	For
3.	ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.	Management	For	For

ALLERGAN PLC
Security	G0177J108	Meeting Type	Special
Ticker Symbol	AGN	Meeting Date	14-Oct-2019
Record Date	16-Sep-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.	COURT MEETING: Approve the scheme of arrangement.	Management	For	For
2.	Extraordinary General Meeting: Approve the scheme of arrangement and authorize the directors of Allergan plc to take all such actions as they consider necessary or appropriate for carrying the scheme of arrangement into effect.	Management	For	For
3.	Extraordinary General Meeting: Approve the cancellation of any Allergan plc ordinary shares in issue at 11:59 p.m., Irish time, on the day before the Irish High Court hearing to sanction the scheme (excluding, in any case, any Allergan plc ordinary shares which are held from time to time by AbbVie Inc., Acquirer Sub (as defined in the scheme of arrangement) or any other subsidiary of AbbVie Inc., if any).	Management	For	For
4.	Extraordinary General Meeting: Authorize the directors of Allergan plc to allot and issue new Allergan plc shares, fully paid up, to Acquirer Sub and/or its nominee(s) in connection with effecting the scheme.	Management	For	For
5.	Extraordinary General Meeting: Amend the articles of association of Allergan plc so that any ordinary shares of Allergan plc that are issued on or after the Voting Record Time (as defined in the scheme of arrangement) to persons other than Acquirer Sub or its nominees will either be subject to the terms of the scheme or will be immediately and automatically acquired by Acquirer Sub and/or its nominee(s) for the scheme consideration.	Management	For	For
6.	Extraordinary General Meeting: Approve, on a non- binding, advisory basis, specified compensatory arrangements between Allergan plc and its named executive officers relating to the transaction.	Management	For	For
7.	Extraordinary General Meeting: Approve any motion by the Chairman to adjourn the extraordinary general meeting, or any adjournments thereof, to solicit additional proxies in favor of the approval of the resolutions if there are insufficient votes at the time of the extraordinary general meeting to approve resolutions 2 through 5.	Management	For	For

AMERISOURCEBERGEN CORPORATION
Security	03073E105	Meeting Type	Annual
Ticker Symbol	ABC	Meeting Date	05-Mar-2020
Record Date	06-Jan-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Ornella Barra	Management	For	For
1B.	Election of Director: Steven H. Collis	Management	For	For
1C.	Election of Director: D. Mark Durcan	Management	For	For
1D.	Election of Director: Richard W. Gochnauer	Management	For	For
1E.	Election of Director: Lon R. Greenberg	Management	For	For
1F.	Election of Director: Jane E. Henney, M.D.	Management	For	For
1G.	Election of Director: Kathleen W. Hyle	Management	For	For
1H.	Election of Director: Michael J. Long	Management	For	For
1I.	Election of Director: Henry W. McGee	Management	For	For
1J.	Election of Director: Dennis M. Nally	Management	For	For
2.	Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2020.	Management	For	For
3.	Advisory vote to approve the compensation of named executive officers.	Management	For	For
4.	Stockholder proposal, if properly presented, to permit stockholders to act by written consent.	Shareholder	Against	For
5.	Stockholder proposal, if properly presented, regarding the use of a deferral period for certain compensation of senior executives.	Shareholder	Against	For

AMGEN INC.
Security	031162100	Meeting Type	Annual
Ticker Symbol	AMGN	Meeting Date	19-May-2020
Record Date	20-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Dr. Wanda M. Austin	Management	For	For
1B.	Election of Director: Mr. Robert A. Bradway	Management	For	For
1C.	Election of Director: Dr. Brian J. Druker	Management	For	For
1D.	Election of Director: Mr. Robert A. Eckert	Management	For	For
1E.	Election of Director: Mr. Greg C. Garland	Management	For	For
1F.	Election of Director: Mr. Fred Hassan	Management	For	For
1G.	Election of Director: Mr. Charles M. Holley, Jr.	Management	For	For
1H.	Election of Director: Dr. Tyler Jacks	Management	For	For
1I.	Election of Director: Ms. Ellen J. Kullman	Management	For	For
1J.	Election of Director: Dr. Ronald D. Sugar	Management	For	For
1K.	Election of Director: Dr. R. Sanders Williams	Management	For	For
2.	Advisory vote to approve our executive compensation.	Management	For	For
3.	To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2020.	Management	For	For
4.	Stockholder proposal to require an independent board chair.	Shareholder	For	Against

ANTHEM, INC.
Security	036752103	Meeting Type	Annual
Ticker Symbol	ANTM	Meeting Date	21-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Gail K. Boudreaux	Management	For	For
1.2	Election of Director: R. Kerry Clark	Management	For	For
1.3	Election of Director: Robert L. Dixon, Jr.	Management	For	For
2.	Advisory vote to approve the compensation of our named executive officers.	Management	For	For
3.	To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2020.	Management	For	For
4.	Shareholder proposal to allow shareholders owning 10% or more of our common stock to call a special meeting of shareholders.	Shareholder	Against	For

ARDELYX, INC
Security	039697107	Meeting Type	Annual
Ticker Symbol	ARDX	Meeting Date	09-Jun-2020
Record Date	15-Apr-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Robert Bazemore		For	For
		2	Gordon Ringold, Ph.D.		For	For
		3	Richard Rodgers		For	For
2.	To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young, LLP as the independent registered public accounting firm of the Company for the fiscal year ended December 31, 2020.			Management	For	For
3.	To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").			Management	For	For
4.	To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years.			Management	1 Year	For

ASTELLAS PHARMA INC.
Security	J03393105	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	18-Jun-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Appoint a Director who is not Audit and Supervisory Committee Member Hatanaka, Yoshihiko	Management	For	For
1.2	Appoint a Director who is not Audit and Supervisory Committee Member Yasukawa, Kenji	Management	For	For
1.3	Appoint a Director who is not Audit and Supervisory Committee Member Okamura, Naoki	Management	For	For
1.4	Appoint a Director who is not Audit and Supervisory Committee Member Sekiyama, Mamoru	Management	For	For
1.5	Appoint a Director who is not Audit and Supervisory Committee Member Yamagami, Keiko	Management	For	For
1.6	Appoint a Director who is not Audit and Supervisory Committee Member Kawabe, Hiroshi	Management	For	For
1.7	Appoint a Director who is not Audit and Supervisory Committee Member Ishizuka, Tatsuro	Management	For	For
2.1	Appoint a Director who is Audit and Supervisory Committee Member Yoshimitsu, Toru	Management	For	For
2.2	Appoint a Director who is Audit and Supervisory Committee Member Sasaki, Hiroo	Management	For	For
2.3	Appoint a Director who is Audit and Supervisory Committee Member Takahashi, Raita	Management	For	For

ASTRAZENECA PLC
Security	046353108	Meeting Type	Annual
Ticker Symbol	AZN	Meeting Date	29-Apr-2020
Record Date	26-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2019	Management	For	For
2.	To confirm dividends	Management	For	For
3.	To reappoint PricewaterhouseCoopers LLP as Auditor	Management	For	For
4.	To authorise the Directors to agree the remuneration of the Auditor	Management	For	For
5A.	Election of Director: Leif Johansson	Management	For	For
5B.	Election of Director: Pascal Soriot	Management	For	For
5C.	Election of Director: Marc Dunoyer	Management	For	For
5D.	Election of Director: Geneviève Berger	Management	For	For
5E.	Election of Director: Philip Broadley	Management	For	For
5F.	Election of Director: Graham Chipchase	Management	For	For
5G.	Election of Director: Michel Demaré	Management	For	For
5H.	Election of Director: Deborah DiSanzo	Management	For	For
5I.	Election of Director: Sheri McCoy	Management	For	For
5J.	Election of Director: Tony Mok	Management	For	For
5K.	Election of Director: Nazneen Rahman	Management	For	For
5l.	Election of Director: Marcus Wallenberg	Management	For	For
6.	To approve the Annual Report on Remuneration for the year ended 31 December 2019	Management	For	For
7.	To approve the Directors' Remuneration Policy	Management	For	For
8.	To authorise limited political donations	Management	For	For
9.	To authorise the Directors to allot shares	Management	For	For
10.	authorise the Directors to disapply pre-emption rights (Special Resolution)	Management	For	For
11.	To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution)	Management	For	For
12.	To authorise the Company to purchase its own shares (Special Resolution)	Management	For	For
13.	To reduce the notice period for general meetings (Special Resolution)	Management	For	For
14.	To approve the 2020 Performance Share Plan	Management	For	For

ATRECA INC
Security	04965G109	Meeting Type	Annual
Ticker Symbol	BCEL	Meeting Date	10-Jun-2020
Record Date	17-Apr-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	David Lacey, MD		For	For
		2	Lindsey Rolfe, MBChB		For	For
2.	Ratification of the selection of OUM & Co. LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020.			Management	For	For

AVADEL PHARMACEUTICALS PLC
Security	05337M104	Meeting Type	Annual
Ticker Symbol	AVDL	Meeting Date	06-Aug-2019
Record Date	30-May-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Gregory J. Divis	Management	For	For
1b.	Election of Director: Dr. Eric J. Ende	Management	For	For
1c.	Election of Director: Geoffrey M. Glass	Management	For	For
1d.	Election of Director: Kevin Kotler	Management	For	For
1e.	Election of Director: Linda S. Palczuk	Management	For	For
1f.	Election of Director: Peter Thornton	Management	For	For
2.	To ratify, in a non-binding vote, the appointment of Deloitte & Touche LLP as the Company's independent registered public auditor and accounting firm for the fiscal year ending December 31, 2019 and to authorize, in a binding vote, the Audit Committee of the Board to set the independent registered public auditor and accounting firm remuneration.	Management	For	For

BAUSCH HEALTH COMPANIES, INC.
Security	071734107	Meeting Type	Annual
Ticker Symbol	BHC	Meeting Date	28-Apr-2020
Record Date	02-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Richard U. De Schutter	Management	For	For
1B.	Election of Director: D. Robert Hale	Management	For	For
1C.	Election of Director: Dr. Argeris (Jerry) N. Karabelas	Management	For	For
1D.	Election of Director: Sarah B. Kavanagh	Management	For	For
1E.	Election of Director: Joseph C. Papa	Management	For	For
1F.	Election of Director: John A. Paulson	Management	For	For
1G.	Election of Director: Robert N. Power	Management	For	For
1H.	Election of Director: Russel C. Robertson	Management	For	For
1I.	Election of Director: Thomas W. Ross, Sr.	Management	For	For
1J.	Election of Director: Andrew C. von Eschenbach, M.D.	Management	For	For
1K.	Election of Director: Amy B. Wechsler, M.D.	Management	For	For
2.	The approval, in an advisory vote, of the compensation of our Named Executive Officers.	Management	For	For
3.	The approval of an amendment to the Company's Amended and Restated 2014 Omnibus Incentive Plan to increase the number of Common Shares authorized under such plan.	Management	For	For
4.	To appoint PricewaterhouseCoopers LLP as the auditors for the Company to hold office until the close of the 2021 Annual Meeting of Shareholders and to authorize the Company's Board of Directors to fix the auditors' remuneration.	Management	For	For

BAXTER INTERNATIONAL INC.
Security	071813109	Meeting Type	Annual
Ticker Symbol	BAX	Meeting Date	05-May-2020
Record Date	12-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: José (Joe) E. Almeida	Management	For	For
1B.	Election of Director: Thomas F. Chen	Management	For	For
1C.	Election of Director: John D. Forsyth	Management	For	For
1D.	Election of Director: James R. Gavin III	Management	For	For
1E.	Election of Director: Peter S. Hellman	Management	For	For
1F.	Election of Director: Michael F. Mahoney	Management	For	For
1G.	Election of Director: Patricia B. Morrison	Management	For	For
1H.	Election of Director: Stephen N. Oesterle	Management	For	For
1I.	Election of Director: Cathy R. Smith	Management	For	For
1J.	Election of Director: Thomas T. Stallkamp	Management	For	For
1K.	Election of Director: Albert P.L. Stroucken	Management	For	For
1L.	Election of Director: Amy A. Wendell	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation	Management	For	For
3.	Ratification of Appointment of Independent Registered Public Accounting Firm	Management	For	For
4.	Stockholder Proposal - Independent Board Chairman	Shareholder	For	Against
5.	Stockholder Proposal - Right to Act by Written Consent	Shareholder	For	Against

BAYER AG
Security	D0712D163	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	28-Apr-2020
Record Date	21-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1	DISTRIBUTION OF THE PROFIT: PAYMENT OF A DIVIDEND OF EUR 2.80 PER DIVIDEND	Management	For	For
2	RATIFICATION OF THE ACTIONS OF THE BOARD OF MANAGEMENT	Management	For	For
3	RATIFICATION OF THE ACTIONS OF THE SUPERVISORY BOARD	Management	For	For
4.A	SUPERVISORY BOARD ELECTION: ERTHARIN COUSIN	Management	For	For
4.B	SUPERVISORY BOARD ELECTION: PROF. DR. MED. DR. H.C. MULT. OTMAR D. WIESTLER	Management	For	For
4.C	SUPERVISORY BOARD ELECTION: HORST BAIER	Management	For	For
5	COMPENSATION SYSTEM FOR THE BOARD OF MANAGEMENT	Management	For	For
6	COMPENSATION OF THE SUPERVISORY BOARD	Management	For	For
7	AMENDMENT OF ARTICLES - SUPERVISORY BOARD MEMBERS' TERM	Management	For	For
8	ELECTION OF THE AUDITOR (FULL-YEAR, HALF- YEAR AND Q3 2020; Q1 2021): DELOITTE GMBH, MUNICH	Management	For	For

BECTON, DICKINSON AND COMPANY
Security	075887109	Meeting Type	Annual
Ticker Symbol	BDX	Meeting Date	28-Jan-2020
Record Date	09-Dec-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Catherine M. Burzik	Management	For	For
1B.	Election of Director: R. Andrew Eckert	Management	For	For
1C.	Election of Director: Vincent A. Forlenza	Management	For	For
1D.	Election of Director: Claire M. Fraser	Management	For	For
1E.	Election of Director: Jeffrey W. Henderson	Management	For	For
1F.	Election of Director: Christopher Jones	Management	For	For
1G.	Election of Director: Marshall O. Larsen	Management	For	For
1H.	Election of Director: David F. Melcher	Management	For	For
1I.	Election of Director: Thomas E. Polen	Management	For	For
1J.	Election of Director: Claire Pomeroy	Management	For	For
1K.	Election of Director: Rebecca W. Rimel	Management	For	For
1L.	Election of Director: Timothy M. Ring	Management	For	For
1M.	Election of Director: Bertram L. Scott	Management	For	For
2.	Ratification of selection of independent registered public accounting firm.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	Approval of amendment to BD's 2004 Employee and Director Equity-Based Compensation Plan.	Management	For	For
5.	Approval of French Addendum to BD'S 2004 Employee and Director Equity-Based Compensation Plan.	Management	For	For
6.	Shareholder proposal regarding special shareholder meetings.	Shareholder	Against	For

BEIGENE LTD
Security	07725L102	Meeting Type	Special
Ticker Symbol	BGNE	Meeting Date	27-Dec-2019
Record Date	27-Nov-2019

Item	Proposal	Proposed by	Vote	For/Against  Management
1	THAT the issuance of approximately 20.5% of the Company's outstanding shares upon closing to Amgen Inc. ("Amgen") be and is hereby approved, pursuant to the terms of the Share Purchase Agreement (the "Share Purchase Agreement") by and between the Company and Amgen.	Management	For	For
2	THAT the Collaboration Agreement (the "Collaboration Agreement") dated October 31, 2019 by and between the Company, BeiGene Switzerland GmbH and Amgen and the transactions contemplated thereunder be and are hereby approved.	Management	For	For
3	THAT the annual caps in relation to the Collaboration Agreement be and are hereby approved.	Management	For	For
4	THAT Anthony C. Hooper be and is hereby elected to serve as a Class III director of the Company until the 2022 annual general meeting of the shareholders of the Company and until his successor is duly elected and qualified, subject to his earlier resignation or removal, subject to and effective upon the closing of the transactions contemplated by the Share Purchase Agreement and the Collaboration Agreement.	Management	For	For

BIOGEN INC.
Security	09062X103	Meeting Type	Annual
Ticker Symbol	BIIB	Meeting Date	03-Jun-2020
Record Date	06-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director for a one year term extending until the 2021 annual meeting: Alexander J. Denner	Management	For	For
1B.	Election of Director for a one year term extending until the 2021 annual meeting: Caroline D. Dorsa	Management	For	For
1C.	Election of Director for a one year term extending until the 2021 annual meeting: William A. Hawkins	Management	For	For
1D.	Election of Director for a one year term extending until the 2021 annual meeting: Nancy L. Leaming	Management	For	For
1E.	Election of Director for a one year term extending until the 2021 annual meeting: Jesus B. Mantas	Management	For	For
1F.	Election of Director for a one year term extending until the 2021 annual meeting: Richard C. Mulligan	Management	For	For
1G.	Election of Director for a one year term extending until the 2021 annual meeting: Robert W. Pangia	Management	For	For
1H.	Election of Director for a one year term extending until the 2021 annual meeting: Stelios Papadopoulos	Management	For	For
1I.	Election of Director for a one year term extending until the 2021 annual meeting: Brian S. Posner	Management	For	For
1J.	Election of Director for a one year term extending until the 2021 annual meeting: Eric K. Rowinsky	Management	For	For
1K.	Election of Director for a one year term extending until the 2021 annual meeting: Stephen A. Sherwin	Management	For	For
1L.	Election of Director for a one year term extending until the 2021 annual meeting: Michel Vounatsos	Management	For	For
2.	To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
3.	Say on Pay - To approve an advisory vote on executive compensation.	Management	For	For

BOSTON SCIENTIFIC CORPORATION
Security	101137107	Meeting Type	Annual
Ticker Symbol	BSX	Meeting Date	07-May-2020
Record Date	13-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Nelda J. Connors	Management	For	For
1B.	Election of Director: Charles J. Dockendorff	Management	For	For
1C.	Election of Director: Yoshiaki Fujimori	Management	For	For
1D.	Election of Director: Donna A. James	Management	For	For
1E.	Election of Director: Edward J. Ludwig	Management	For	For
1F.	Election of Director: Stephen P. MacMillan	Management	For	For
1G.	Election of Director: Michael F. Mahoney	Management	For	For
1H.	Election of Director: David J. Roux	Management	For	For
1I.	Election of Director: John E. Sununu	Management	For	For
1J.	Election of Director: Ellen M. Zane	Management	For	For
2.	To approve, on a non-binding, advisory basis, named executive officer compensation.	Management	For	For
3.	To approve an amendment and restatement of the Company's 2011 Long-Term Incentive Plan.	Management	For	For
4.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2020 fiscal year.	Management	For	For
5.	To consider and vote upon a stockholder proposal requesting a report on inclusion of non-management employee representation on the Board of Directors.	Shareholder	Against	For

BRISTOL-MYERS SQUIBB COMPANY
Security	110122108	Meeting Type	Annual
Ticker Symbol	BMY	Meeting Date	05-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Peter J. Arduini	Management	For	For
1B.	Election of Director: Robert Bertolini	Management	For	For
1C.	Election of Director: Michael W. Bonney	Management	For	For
1D.	Election of Director: Giovanni Caforio, M.D.	Management	For	For
1E.	Election of Director: Matthew W. Emmens	Management	For	For
1F.	Election of Director: Julia A. Haller, M.D.	Management	For	For
1G.	Election of Director: Dinesh C. Paliwal	Management	For	For
1H.	Election of Director: Theodore R. Samuels	Management	For	For
1I.	Election of Director: Vicki L. Sato, Ph.D.	Management	For	For
1J.	Election of Director: Gerald L. Storch	Management	For	For
1K.	Election of Director: Karen H. Vousden, Ph.D.	Management	For	For
1L.	Election of Director: Phyllis R. Yale	Management	For	For
2.	Advisory vote to approve the compensation of our Named Executive Officers.	Management	For	For
3.	Ratification of the appointment of an independent registered public accounting firm.	Management	For	For
4.	Shareholder Proposal on Separate Chair & CEO.	Shareholder	For	Against
5.	Shareholder Proposal on Shareholder Right to Act by Written Consent.	Shareholder	Against	For

CARDINAL HEALTH, INC.
Security	14149Y108	Meeting Type	Annual
Ticker Symbol	CAH	Meeting Date	06-Nov-2019
Record Date	09-Sep-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Colleen F. Arnold	Management	For	For
1B.	Election of Director: Carrie S. Cox	Management	For	For
1C.	Election of Director: Calvin Darden	Management	For	For
1D.	Election of Director: Bruce L. Downey	Management	For	For
1E.	Election of Director: Patricia A. Hemingway Hall	Management	For	For
1F.	Election of Director: Akhil Johri	Management	For	For
1G.	Election of Director: Michael C. Kaufmann	Management	For	For
1H.	Election of Director: Gregory B. Kenny	Management	For	For
1I.	Election of Director: Nancy Killefer	Management	For	For
1J.	Election of Director: J. Michael Losh	Management	For	For
1K.	Election of Director: Dean A. Scarborough	Management	For	For
1L.	Election of Director: John H. Weiland	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2020.	Management	For	For
3.	To approve, on a non-binding advisory basis, the compensation of our named executive officers.	Management	For	For

CELLDEX THERAPEUTICS, INC.
Security	15117B202	Meeting Type	Annual
Ticker Symbol	CLDX	Meeting Date	18-Jun-2020
Record Date	21-Apr-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Karen L. Shoos		For	For
		2	Anthony S. Marucci		For	For
		3	Keith L. Brownlie		For	For
		4	Herbert J. Conrad		For	For
		5	James J. Marino		For	For
		6	Harry H. Penner, Jr.		For	For
2.	To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2020.			Management	For	For
3.	To approve an amendment to our 2008 Stock Option and Incentive Plan including an increase in the number of the shares reserved for issuance thereunder by 1,900,000 shares to 4,133,333 shares.			Management	For	For
4.	To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this proxy statement.			Management	For	For

CELLECTIS S.A.
Security	15117K103	Meeting Type	Annual
Ticker Symbol	CLLS	Meeting Date	29-Jun-2020
Record Date	22-May-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the financial statements for the financial year ended December 31, 2019.	Management	For	For
2.	Approval of the consolidated financial statements for the financial year ended December 31, 2019.	Management	For	For
3.	Allocation of income for the financial year ended December 31, 2019.	Management	For	For
4.	Approval of the agreements referred to in articles L. 225- 38 and the following sections of the French commercial code.	Management	For	For
5.	Setting the amount of the total compensation (directors fees) to be granted to the non-executive directors.	Management	For	For
6.	Renewal of the mandate of a member of the Board of Directors of Mrs. Annick Schwebig.	Management	For	For
7.	Renewal of the mandate of a member of the Board of Directors of Mr. Laurent Arthaud.	Management	For	For
8.	Renewal of the mandate of a member of the Board of Directors of Mr. Pierre Bastid.	Management	For	For
9.	Renewal of the mandate of a member of the Board of Directors of Mr. Rainer Boehm.	Management	For	For
10.	Renewal of the mandate of a member of the Board of Directors of Mr. Hervé Hoppenot.	Management	For	For
11.	Authorization to be given to the board of directors to buy back Company shares.	Management	For	For

12.	Authorization to be given to the board of directors for the ...(due to space limits, see proxy material for full proposal).	Management	For	For
13.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
14.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
15.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
16.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
17.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
18.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
19.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
20.	Delegation granted to the board of directors to increase the ...(due to space limits, see proxy material for full proposal).	Management	For	For
21.	Overall limitations to the amount of issuances made under the ...(due to space limits, see proxy material for full proposal).	Management	For	For
22.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
23.	Authorization to be given to the board of directors to grant options to subscribe or purchase Company's shares.	Management	For	For
24.	Authorization be given to the board of directors for the ...(due to space limits, see proxy material for full proposal).	Management	For	For
25.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
26.	Overall limitations to the amount of issues made under the 23rd resolution, 24th resolution and the 25th resolution above.	Management	For	For
27.	Amendment of article 12 of the articles of association "meeting ...(due to space limits, see proxy material for full proposal).	Management	For	For
28.	Amendment of Article 18 of the Articles of Association "General ...(due to space limits, see proxy material for full proposal).	Management	For	For
29.	Delegation to be granted to the board of directors for the ...(due to space limits, see proxy material for full proposal).	Management	Against	For

CELLECTIS S.A.
Security	15117K103	Meeting Type	Annual
Ticker Symbol	CLLS	Meeting Date	29-Jun-2020
Record Date	11-Jun-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the financial statements for the financial year ended December 31, 2019.	Management	For	For
2.	Approval of the consolidated financial statements for the financial year ended December 31, 2019.	Management	For	For
3.	Allocation of income for the financial year ended December 31, 2019.	Management	For	For
4.	Approval of the agreements referred to in articles L. 225-38 and the following sections of the French commercial code.	Management	For	For
5.	Setting the amount of the total compensation (directors fees) to be granted to the non-executive directors.	Management	For	For
6.	Renewal of the mandate of a member of the Board of Directors of Mrs. Annick Schwebig.	Management	For	For
7.	Renewal of the mandate of a member of the Board of Directors of Mr. Laurent Arthaud.	Management	For	For
8.	Renewal of the mandate of a member of the Board of Directors of Mr. Pierre Bastid.	Management	For	For
9.	Renewal of the mandate of a member of the Board of Directors of Mr. Rainer Boehm.	Management	For	For
10.	Renewal of the mandate of a member of the Board of Directors of Mr. Hervé Hoppenot.	Management	For	For
11.	Authorization to be given to the board of directors to buy back Company shares.	Management	For	For

12.	Authorization to be given to the board of directors for the ...(due to space limits, see proxy material for full proposal).	Management	For	For
13.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
14.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
15.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
16.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
17.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
18.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
19.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
20.	Delegation granted to the board of directors to increase the ...(due to space limits, see proxy material for full proposal).	Management	For	For
21.	Overall limitations to the amount of issuances made under the ...(due to space limits, see proxy material for full proposal).	Management	For	For
22.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
23.	Authorization to be given to the board of directors to grant options to subscribe or purchase Company's shares.	Management	For	For
24.	Authorization be given to the board of directors for the ...(due to space limits, see proxy material for full proposal).	Management	For	For
25.	Delegation of authority to be granted to the board of directors ...(due to space limits, see proxy material for full proposal).	Management	For	For
26.	Overall limitations to the amount of issues made under the 23rd resolution, 24th resolution and the 25th resolution above.	Management	For	For
27.	Amendment of article 12 of the articles of association "meeting ...(due to space limits, see proxy material for full proposal).	Management	For	For
28.	Amendment of Article 18 of the Articles of Association "General ...(due to space limits, see proxy material for full proposal).	Management	For	For
29.	Delegation to be granted to the board of directors for the ...(due to space limits, see proxy material for full proposal).	Management	Against	For

CENTENE CORPORATION
Security	15135B101	Meeting Type	Annual
Ticker Symbol	CNC	Meeting Date	28-Apr-2020
Record Date	28-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	ELECTION OF DIRECTOR: Michael F. Neidorff	Management	For	For
1B.	ELECTION OF DIRECTOR: H. James Dallas	Management	For	For
1C.	ELECTION OF DIRECTOR: Robert K. Ditmore	Management	For	For
1D.	ELECTION OF DIRECTOR: Richard A. Gephardt	Management	For	For
1E.	ELECTION OF DIRECTOR: Lori J. Robinson	Management	For	For
1F.	ELECTION OF DIRECTOR: William L. Trubeck	Management	For	For
2.	ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.	Management	For	For
3.	RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2020.	Management	For	For
4.	APPROVAL OF AMENDMENT TO THE 2002 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED AND RESTATED.	Management	For	For
5.	THE STOCKHOLDER PROPOSAL ON POLITICAL SPENDING DISCLOSURES AS DESCRIBED IN THE PROXY STATEMENT.	Shareholder	Against	For
6.	THE STOCKHOLDER PROPOSAL ON THE ELIMINATION OF SUPERMAJORITY VOTING PROVISIONS AS DESCRIBED IN THE PROXY STATEMENT.	Shareholder	Against	For

CERNER CORPORATION
Security	156782104	Meeting Type	Annual
Ticker Symbol	CERN	Meeting Date	22-May-2020
Record Date	24-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Class I Director: Julie L. Gerberding, M.D., M.P.H.	Management	For	For
1b.	Election of Class I Director: Brent Shafer	Management	For	For
1c.	Election of Class I Director: William D. Zollars	Management	For	For
2.	Ratification of the appointment of KPMG LLP as the independent registered public accounting firm of Cerner Corporation for 2020.	Management	For	For
3.	Approval, on an advisory basis, of the compensation of our Named Executive Officers.	Management	For	For
4.	Approval of the proposed amendment to our Third Restated Certificate of Incorporation to declassify the Board of Directors.	Management	For	For
5.	Approval of the proposed amendment to our Third Restated Certificate of Incorporation to amend the advance notice provisions for director nominations.	Management	For	For

CHUGAI PHARMACEUTICAL CO.,LTD.
Security	J06930101	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	30-Mar-2020
Record Date	31-Dec-2019

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director Kosaka, Tatsuro	Management	For	For
2.2	Appoint a Director Ueno, Motoo	Management	For	For
2.3	Appoint a Director Okuda, Osamu	Management	For	For
2.4	Appoint a Director Momoi, Mariko	Management	For	For
3.1	Appoint a Corporate Auditor Nimura, Takaaki	Management	For	For
3.2	Appoint a Corporate Auditor Masuda, Kenichi	Management	For	For
4	Approve Details of the Compensation to be received by Corporate Auditors	Management	For	For

CIGNA CORPORATION
Security	125523100	Meeting Type	Annual
Ticker Symbol	CI	Meeting Date	22-Apr-2020
Record Date	24-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: David M. Cordani	Management	For	For
1B.	Election of Director: William J. DeLaney	Management	For	For
1C.	Election of Director: Eric J. Foss	Management	For	For
1D.	Election of Director: Elder Granger, MD, MG, USA	Management	For	For
1E.	Election of Director: Isaiah Harris, Jr.	Management	For	For
1F.	Election of Director: Roman Martinez IV	Management	For	For
1G.	Election of Director: Kathleen M. Mazzarella	Management	For	For
1H.	Election of Director: Mark B. McClellan, MD, PhD	Management	For	For
1I.	Election of Director: John M. Partridge	Management	For	For
1J.	Election of Director: William L. Roper, MD, MPH	Management	For	For
1K.	Election of Director: Eric C. Wiseman	Management	For	For
1L.	Election of Director: Donna F. Zarcone	Management	For	For
2.	Advisory approval of Cigna's executive compensation.	Management	For	For
3.	Ratification of appointment of PricewaterhouseCoopers LLP as Cigna's independent registered public accounting firm for 2020.	Management	For	For
4.	Shareholder proposal - Shareholder right to call a special meeting.	Shareholder	Against	For
5.	Shareholder proposal - Gender pay gap report.	Shareholder	Against	For

COMMUNITY HEALTH SYSTEMS, INC.
Security	203668108	Meeting Type	Annual
Ticker Symbol	CYH	Meeting Date	12-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: John A. Clerico	Management	For	For
1B.	Election of Director: Michael Dinkins	Management	For	For
1C.	Election of Director: James S. Ely III	Management	For	For
1D.	Election of Director: John A. Fry	Management	For	For
1E.	Election of Director: Tim L. Hingtgen	Management	For	For
1F.	Election of Director: Elizabeth T. Hirsch	Management	For	For
1G.	Election of Director: William Norris Jennings, M.D.	Management	For	For
1H.	Election of Director: K. Ranga Krishnan, MBBS	Management	For	For
1I.	Election of Director: Julia B. North	Management	For	For
1J.	Election of Director: Wayne T. Smith	Management	For	For
1K.	Election of Director: H. James Williams, Ph.D.	Management	For	For
2.	Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.	Management	For	For
3.	Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors on March 20, 2020, subject to stockholder approval.	Management	For	For
4.	Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For

COMMUNITY HEALTHCARE TRUST INCORPORATED
Security	20369C106	Meeting Type	Annual
Ticker Symbol	CHCT	Meeting Date	07-May-2020
Record Date	06-Mar-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Alan Gardner		For	For
	2	Claire Gulmi		For	For
	3	Robert Hensley		For	For
	4	Lawrence Van Horn		For	For
	5	Timothy Wallace		For	For
2.	To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the stockholders of Community Healthcare Trust Incorporated approve, on a non-binding advisory basis, the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2020 annual meeting of stockholders.		Management	For	For
3.	To approve, on a non-binding advisory basis, the frequency of a non-binding advisory vote on executive compensation.		Management	1 Year	For
4.	To ratify the appointment of BDO USA, LLP as the Company's independent registered public accountants for 2020.		Management	For	For

CSL LTD
Security	Q3018U109	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	16-Oct-2019
Record Date	14-Oct-2019

Item	Proposal	Proposed by	Vote	For/Against Management
2.A.	TO RE-ELECT MS MARIE MCDONALD AS A DIRECTOR	Management	For	For
2.B.	TO RE-ELECT DR MEGAN CLARK AC AS A DIRECTOR	Management	For	For
3.	ADOPTION OF THE REMUNERATION REPORT	Management	For	For
4.A.	APPROVAL OF A GRANT OF PERFORMANCE SHARE UNITS TO EXECUTIVE DIRECTOR, MR PAUL PERREAULT	Management	For	For
4.B.	APPROVAL OF A GRANT OF PERFORMANCE SHARE UNITS TO EXECUTIVE DIRECTOR, PROFESSOR ANDREW CUTHBERTSON AO	Management	For	For

CVS HEALTH CORPORATION
Security	126650100	Meeting Type	Annual
Ticker Symbol	CVS	Meeting Date	14-May-2020
Record Date	18-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Fernando Aguirre	Management	For	For
1B.	Election of Director: C. David Brown II	Management	For	For
1C.	Election of Director: Alecia A. DeCoudreaux	Management	For	For
1D.	Election of Director: Nancy-Ann M. DeParle	Management	For	For
1E.	Election of Director: David W. Dorman	Management	For	For
1F.	Election of Director: Roger N. Farah	Management	For	For
1G.	Election of Director: Anne M. Finucane	Management	For	For
1H.	Election of Director: Edward J. Ludwig	Management	For	For
1I.	Election of Director: Larry J. Merlo	Management	For	For
1J.	Election of Director: Jean-Pierre Millon	Management	For	For
1K.	Election of Director: Mary L. Schapiro	Management	For	For
1L.	Election of Director: William C. Weldon	Management	For	For
1M.	Election of Director: Tony L. White	Management	For	For
2.	Ratification of the appointment of our independent registered public accounting firm for 2020.	Management	For	For
3.	Say on Pay, a proposal to approve, on an advisory basis, the Company's executive compensation.	Management	For	For
4.	Proposal to amend the Company's 2017 Incentive Compensation Plan to increase the number of shares authorized to be issued under the Plan.	Management	For	For
5.	Proposal to amend the Company's 2007 Employee Stock Purchase Plan to increase the number of shares available for sale under the Plan.	Management	For	For
6.	Stockholder proposal for reducing the ownership threshold to request a stockholder action by written consent.	Shareholder	Against	For
7.	Stockholder proposal regarding our independent Board Chair.	Shareholder	Against	For

DAIICHI SANKYO COMPANY, LIMITED
Security	J11257102	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	15-Jun-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director Manabe, Sunao	Management	For	For
2.2	Appoint a Director Sai, Toshiaki	Management	For	For
2.3	Appoint a Director Kimura, Satoru	Management	For	For
2.4	Appoint a Director Uji, Noritaka	Management	For	For
2.5	Appoint a Director Fukui, Tsuguya	Management	For	For
2.6	Appoint a Director Kama, Kazuaki	Management	For	For
2.7	Appoint a Director Nohara, Sawako	Management	For	For
2.8	Appoint a Director Otsuki, Masahiko	Management	For	For
2.9	Appoint a Director Hirashima, Shoji	Management	For	For
3	Approve Payment of Bonuses to Directors	Management	For	For
4	Approve Details of the Restricted-Share Compensation to be received by Directors (Excluding Outside Directors)	Management	For	For

DANAHER CORPORATION
Security	235851102	Meeting Type	Annual
Ticker Symbol	DHR	Meeting Date	05-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Linda Hefner Filler	Management	For	For
1B.	Election of Director: Thomas P. Joyce, Jr.	Management	For	For
1C.	Election of Director: Teri List-Stoll	Management	For	For
1D.	Election of Director: Walter G. Lohr, Jr.	Management	For	For
1E.	Election of Director: Jessica L. Mega, MD, MPH	Management	For	For
1F.	Election of Director: Pardis C. Sabeti, MD, D. Phil.	Management	For	For
1G.	Election of Director: Mitchell P. Rales	Management	For	For
1H.	Election of Director: Steven M. Rales	Management	For	For
1I.	Election of Director: John T. Schwieters	Management	For	For
1J.	Election of Director: Alan G. Spoon	Management	For	For
1K.	Election of Director: Raymond C. Stevens, Ph.D.	Management	For	For
1L.	Election of Director: Elias A. Zerhouni, MD	Management	For	For
2.	To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2020	Management	For	For
3.	To approve on an advisory basis the Company's named executive officer compensation	Management	For	For
4.	To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10%	Shareholder	Against	For

DENTSPLY SIRONA INC.
Security	24906P109	Meeting Type	Annual
Ticker Symbol	XRAY	Meeting Date	20-May-2020
Record Date	23-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Michael C. Alfano	Management	For	For
1B.	Election of Director: Eric K. Brandt	Management	For	For
1C.	Election of Director: Donald M. Casey Jr.	Management	For	For
1D.	Election of Director: Willie A. Deese	Management	For	For
1E.	Election of Director: Betsy D. Holden	Management	For	For
1F.	Election of Director: Arthur D. Kowaloff	Management	For	For
1G.	Election of Director: Harry M. Kraemer Jr.	Management	For	For
1H.	Election of Director: Gregory T. Lucier	Management	For	For
1I.	Election of Director: Francis J. Lunger	Management	For	For
1J.	Election of Director: Leslie F. Varon	Management	For	For
1K.	Election of Director: Janet S. Vergis	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for 2020.	Management	For	For
3.	Approval, by non-binding vote, of the Company's executive compensation.	Management	For	For

DECIPHER BIOSCIENCES, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	16-Sep-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Amendment of 2018 Equity Incentive Plan	Management	For	For
2.	General Authorizing Resolution	Management	For	For

DECIPHER BIOSCIENCES, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	14-May-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Amendment and Restatement of Certification of Incorporation	Management	For	For
2.	Series 4 Preferred Stock and Note Financing	Management	For	For
3.	Amendment of 2018 Equity Incentive Plan	Management	For	For
4.	General Authorizing Resolution	Management	For	For

DIVERSIFIED HEALTHCARE TRUST
Security	25525P107	Meeting Type	Annual
Ticker Symbol	DHC	Meeting Date	19-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Independent Class III Trustee: Jeffrey P. Somers	Management	For	For
2.	Approve an amendment to the Company's Declaration of Trust to provide for the annual election of all Trustees.	Management	For	For
3.	Advisory vote to approve executive compensation.	Management	For	For
4.	Ratification of the appointment of Ernst & Young LLP as independent auditors to serve for the 2020 fiscal year.	Management	For	For

DYNACURE
Security	N/A	Meeting Type	Annual Meeting
Ticker Symbol	N/A	Meeting Date	16-Jun-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Waiver of the period and form of prior notice	Management	For	For
2.	Approval of the financial statements for the financial year ended on December 31, 2019; Discharge to the Chairman for his duties during the past financial year	Management	For	For
3.	Allocation of the result of the financial year ended on December 31, 2019	Management	For	For
4.	Review and approval of the Statutory Auditors' special report on the agreements referred to in Article L. 227-10 of the French commercial code	Management	For	For
5.	Renewal of the terms of office of Brett Monia, Raphael Wisniewski, Remi Droller and Georges Gemayel, in their capacity as members of the Supervisory Board	Management	For	For
6.	Acknowledgement of the resignation of Caroline Dreyer and Philippe Guinot from their duties as observers of the Supervisory Board and appointment of new observers of the Supervisory Board	Management	For	For
7.	Powers to carry out formalities	Management	For	For

EDWARDS LIFESCIENCES CORPORATION
Security	28176E108	Meeting Type	Annual
Ticker Symbol	EW	Meeting Date	07-May-2020
Record Date	13-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Michael A. Mussallem	Management	For	For
1B.	Election of Director: Kieran T. Gallahue	Management	For	For
1C.	Election of Director: Leslie S. Heisz	Management	For	For
1D.	Election of Director: William J. Link, Ph.D.	Management	For	For
1E.	Election of Director: Steven R. Loranger	Management	For	For
1F.	Election of Director: Martha H. Marsh	Management	For	For
1G.	Election of Director: Ramona Sequeira	Management	For	For
1H.	Election of Director: Nicholas J. Valeriani	Management	For	For
2.	ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS.	Management	For	For
3.	APPROVAL OF THE 2020 NONEMPLOYEE DIRECTORS STOCK INCENTIVE PROGRAM.	Management	For	For
4.	APPROVAL OF AMENDMENT OF THE CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FOR THE PURPOSE OF EFFECTING A THREE-FOR-ONE STOCK SPLIT.	Management	For	For
5.	RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	Management	For	For
6.	ADVISORY VOTE ON A STOCKHOLDER PROPOSAL REGARDING ACTION BY WRITTEN CONSENT.	Shareholder	Against	For

EISAI CO.,LTD.
Security	J12852117	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	19-Jun-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1.1	Appoint a Director Naito, Haruo	Management	For	For
1.2	Appoint a Director Kato, Yasuhiko	Management	For	For
1.3	Appoint a Director Kanai, Hirokazu	Management	For	For
1.4	Appoint a Director Tsunoda, Daiken	Management	For	For
1.5	Appoint a Director Bruce Aronson	Management	For	For
1.6	Appoint a Director Tsuchiya, Yutaka	Management	For	For
1.7	Appoint a Director Kaihori, Shuzo	Management	For	For
1.8	Appoint a Director Murata, Ryuichi	Management	For	For
1.9	Appoint a Director Uchiyama, Hideyo	Management	For	For
1.10	Appoint a Director Hayashi, Hideki	Management	For	For
1.11	Appoint a Director Miwa, Yumiko	Management	For	For

ELI LILLY AND COMPANY
Security	532457108	Meeting Type	Annual
Ticker Symbol	LLY	Meeting Date	04-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: M. L. Eskew	Management	For	For
1B.	Election of Director: W. G. Kaelin, Jr.	Management	For	For
1C.	Election of Director: D. A. Ricks	Management	For	For
1D.	Election of Director: M. S. Runge	Management	For	For
1E.	Election of Director: K. Walker	Management	For	For
2.	Approval, by non-binding vote, of the compensation paid to the company's named executive officers.	Management	For	For
3.	Ratification of Ernst & Young LLP as the independent auditor for 2020.	Management	For	For
4.	Approve amendments to the Articles of Incorporation to eliminate the classified board structure.	Management	For	For
5.	Approve amendments to the Articles of Incorporation to eliminate supermajority voting provisions.	Management	For	For
6.	Shareholder proposal to disclose direct and indirect lobbying activities and expenditures.	Shareholder	Against	For
7.	Shareholder proposal to publish a report on the effectiveness of the forced swim test.	Shareholder	Against	For
8.	Shareholder proposal to amend the bylaws to require an independent board chair.	Shareholder	For	Against
9.	Shareholder proposal on board diversity requesting disclosures of specific minimum qualifications and board nominee skills, experience, and ideological perspective.	Shareholder	Against	For
10.	Shareholder proposal to publish feasibility report on incorporating public concern over drug prices into senior executive compensation arrangements.	Shareholder	Against	For
11.	Shareholder proposal to implement a bonus deferral policy.	Shareholder	Against	For
12.	Shareholder proposal to disclose clawbacks on executive incentive compensation due to misconduct.	Shareholder	Against	For

ENDO INTERNATIONAL PLC
Security	G30401106	Meeting Type	Annual
Ticker Symbol	ENDP	Meeting Date	11-Jun-2020
Record Date	13-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Paul V. Campanelli	Management	For	For
1B.	Election of Director: Blaise Coleman	Management	For	For
1C.	Election of Director: Mark G. Barberio	Management	For	For
1D.	Election of Director: Shane M. Cooke	Management	For	For
1E.	Election of Director: Nancy J. Hutson, Ph.D.	Management	For	For
1F.	Election of Director: Michael Hyatt	Management	For	For
1G.	Election of Director: Roger H. Kimmel	Management	For	For
1H.	Election of Director: William P. Montague	Management	For	For
2.	To approve, by advisory vote, named executive officer compensation.	Management	For	For
3.	To approve the Endo International plc Amended and Restated 2015 Stock Incentive Plan.	Management	For	For
4.	To renew the Board's existing authority to issue shares under Irish law.	Management	For	For
5.	To renew the Board's existing authority to opt-out of statutory pre-emption rights under Irish law.	Management	For	For
6.	To approve the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2020 and to authorize the Board of Directors, acting through the Audit Committee, to determine the independent registered public accounting firm's remuneration.	Management	For	For

FIVE STAR SENIOR LIVING INC.
Security	33832D205	Meeting Type	Annual
Ticker Symbol	FVE	Meeting Date	09-Jun-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director (for Independent Director in Group I): Barbara D. Gilmore	Management	For	For
1.2	Election of Director (for Managing Director in Group I): Adam D. Portnoy	Management	For	For
2.	Approval of the Company's Amended and Restated 2014 Equity Compensation Plan.	Management	For	For
3.	Advisory vote to approve executive compensation.	Management	For	For
4.	Ratification of the appointment of RSM US LLP as independent auditors to serve for the 2020 fiscal year.	Management	For	For

GALERA THERAPEUTICS, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	9-Jul-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Election of Lawrence Alleva to the Board of Directors	Management	For	For
2.	General Enabling Resolutions	Management	For	For

GALERA THERAPEUTICS, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	16-Oct-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Form of Lock-Up Agreement	Management	For	For

GALERA THERAPEUTICS, INC.
Security	36338D108	Meeting Type	Annual
Ticker Symbol	GRTX	Meeting Date	09-Jun-2020
Record Date	16-Apr-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Michael Powell, Ph.D.		For	For
		2	Linda West		For	For
2.	To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.			Management	For	For

GENMAB A/S
Security	K3967W102	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	26-Mar-2020
Record Date	19-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1	REPORT BY THE BOARD OF DIRECTORS ON THE COMPANY'S ACTIVITIES DURING THE YEAR	Non-Voting
2	ADOPTION OF THE AUDITED ANNUAL REPORT AND DISCHARGE OF THE BOARD OF DIRECTORS AND THE EXECUTIVE MANAGEMENT	Management	For	For
3	DECISION AS TO THE DISTRIBUTION OF PROFIT ACCORDING TO THE ADOPTED ANNUAL REPORT	Management	For	For
4.A	RE-ELECTION OF DEIRDRE P. CONNELLY AS A MEMBER OF BOARD OF DIRECTOR	Management	For	For
4.B	RE-ELECTION OF PERNILLE ERENBJERG AS A MEMBER OF BOARD OF DIRECTOR	Management	For	For
4.C	RE-ELECTION OF ROLF HOFFMANN AS A MEMBER OF BOARD OF DIRECTOR	Management	For	For
4.D	RE-ELECTION OF DR. PAOLO PAOLETTI AS A MEMBER OF BOARD OF DIRECTOR	Management	For	For
4.E	RE-ELECTION OF DR. ANDERS GERSEL PEDERSEN AS A MEMBER OF BOARD OF DIRECTOR	Management	For	For
4.F	ELECTION OF JONATHAN PEACOCK AS A MEMBER OF BOARD OF DIRECTOR	Management	For	For
5	RE-ELECTION OF PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB AS AN AUDITOR	Management	For	For
6.A	PROPOSAL FROM THE BOARD OF DIRECTORS: ADOPTION OF THE REMUNERATION POLICY FOR THE BOARD OF DIRECTORS AND THE EXECUTIVE MANAGEMENT	Management	For	For
6.B	PROPOSAL FROM THE BOARD OF DIRECTORS: APPROVAL OF THE BOARD OF DIRECTORS' REMUNERATION FOR 2020	Management	For	For
6.C	PROPOSAL FROM THE BOARD OF DIRECTORS: AMENDMENT OF ARTICLE 6 (PROVIDER OF SHARE REGISTRATION SERVICES)	Management	For	For
7	AUTHORIZATION OF THE CHAIRMAN OF THE GENERAL MEETING TO REGISTER RESOLUTIONS PASSED BY THE GENERAL MEETING	Management	For	For
8	MISCELLANEOUS	Non-Voting

GILEAD SCIENCES, INC.
Security	375558103	Meeting Type	Annual
Ticker Symbol	GILD	Meeting Date	06-May-2020
Record Date	13-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Jacqueline K. Barton, Ph.D.	Management	For	For
1B.	Election of Director: Sandra J. Horning, M.D.	Management	For	For
1C.	Election of Director: Kelly A. Kramer	Management	For	For
1D.	Election of Director: Kevin E. Lofton	Management	For	For
1E.	Election of Director: Harish Manwani	Management	For	For
1F.	Election of Director: Daniel P. O'Day	Management	For	For
1G.	Election of Director: Richard J. Whitley, M.D.	Management	For	For
1H.	Election of Director: Per Wold-Olsen	Management	For	For
2.	To ratify the selection of Ernst & Young LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2020.	Management	For	For
3.	To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.	Management	For	For
4.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director.	Shareholder	For	Against
5.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board eliminate the ownership threshold for stockholders to request a record date to take action by written consent.	Shareholder	For	Against

GLAXOSMITHKLINE PLC
Security	37733W105	Meeting Type	Annual
Ticker Symbol	GSK	Meeting Date	06-May-2020
Record Date	16-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
O1.	To receive and adopt the 2019 Annual Report	Management	For	For
O2.	To approve the Annual report on remuneration	Management	For	For
O3.	To approve the Remuneration policy	Management	For	For
O4.	To elect Sir Jonathan Symonds as a Director	Management	For	For
05.	To elect Charles Bancroft as a Director	Management	For	For
O6.	To re-elect Emma Walmsley as a Director	Management	For	For
O7.	To re-elect Vindi Banga as a Director	Management	For	For
O8.	To re-elect Dr Hal Barron as a Director	Management	For	For
O9.	To re-elect Dr Vivienne Cox as a Director	Management	For	For
O10.	To re-elect Lynn Elsenhans as a Director	Management	For	For
O11.	To re-elect Dr Laurie Glimcher as a Director	Management	For	For
O12.	To re-elect Dr Jesse Goodman as a Director	Management	For	For
O13.	To re-elect Judy Lewent as a Director	Management	For	For
O14.	To re-elect Iain Mackay as a Director	Management	For	For
O15.	To re-elect Urs Rohner as a Director	Management	For	For
O16.	To re-appoint the auditor	Management	For	For
O17.	To determine remuneration of the auditor	Management	For	For
S18.	To authorise the company and its subsidiaries to make donations to political organisations and incur political expenditure	Management	For	For
S19.	To authorise allotment of shares	Management	For	For
S20.	To disapply pre-emption rights - general power (special resolution)	Management	For	For
S21.	To disapply pre-emption rights - in connection with an acquisition or specified capital investment (special resolution)	Management	For	For
S22.	To authorise the company to purchase its own shares (special resolution)	Management	For	For
S23.	To authorise exemption from statement of name of senior statutory auditor	Management	For	For
S24.	To authorise reduced notice of a general meeting other than an AGM (special resolution)	Management	For	For

HCA HEALTHCARE, INC.
Security	40412C101	Meeting Type	Annual
Ticker Symbol	HCA	Meeting Date	01-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Thomas F. Frist III	Management	For	For
1B.	Election of Director: Samuel N. Hazen	Management	For	For
1C.	Election of Director: Meg G. Crofton	Management	For	For
1D.	Election of Director: Robert J. Dennis	Management	For	For
1E.	Election of Director: Nancy-Ann DeParle	Management	For	For
1F.	Election of Director: William R. Frist	Management	For	For
1G.	Election of Director: Charles O. Holliday, Jr.	Management	For	For
1H.	Election of Director: Michael W. Michelson	Management	For	For
1I.	Election of Director: Wayne J. Riley, M.D.	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2020.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	To approve the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates.	Management	For	For
5.	To approve an amendment to our amended and restated certificate of incorporation to allow stockholders owning an aggregate of 15% of our outstanding common stock to request special meetings of stockholders.	Management	For	For
6.	Stockholder proposal, if properly presented at the meeting, requesting that the Board of Directors take the steps necessary to allow stockholders to act by written consent.	Shareholder	Against	For

HEALTHCARE REALTY TRUST INCORPORATED
Security	421946104	Meeting Type	Annual
Ticker Symbol	HR	Meeting Date	12-May-2020
Record Date	13-Mar-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Todd J. Meredith		For	For
		2	John V. Abbott		For	For
		3	Nancy H. Agee		For	For
		4	Edward H. Braman		For	For
		5	James J. Kilroy		For	For
		6	Peter F. Lyle, Sr.		For	For
		7	John Knox Singleton		For	For
		8	Bruce D. Sullivan		For	For
		9	Christann M. Vasquez		For	For
2.	To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2020 fiscal year.			Management	For	For
3.	To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the shareholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2020 Annual Meeting of Shareholders.			Management	For	For

HEALTHCARE TRUST OF AMERICA, INC.
Security	42225P501	Meeting Type	Annual
Ticker Symbol	HTA	Meeting Date	07-Jul-2020
Record Date	15-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Scott D. Peters	Management	For	For
1B.	Election of Director: W. Bradley Blair, II	Management	For	For
1C.	Election of Director: Vicki U. Booth	Management	For	For
1D.	Election of Director: H. Lee Cooper	Management	For	For
1E.	Election of Director: Warren D. Fix	Management	For	For
1F.	Election of Director: Peter N. Foss	Management	For	For
1G.	Election of Director: Jay P. Leupp	Management	For	For
1H.	Election of Director: Gary T. Wescombe	Management	For	For
2.	To approve, on an advisory vote, the compensation of our named executive officers.	Management	For	For
3.	To consider and vote upon the ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2020.	Management	For	For

HEALTHPEAK PROPERTIES, INC
Security	42250P103	Meeting Type	Annual
Ticker Symbol	PEAK	Meeting Date	23-Apr-2020
Record Date	02-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Brian G. Cartwright	Management	For	For
1B.	Election of Director: Christine N. Garvey	Management	For	For
1C.	Election of Director: R. Kent Griffin, Jr.	Management	For	For
1D.	Election of Director: David B. Henry	Management	For	For
1E.	Election of Director: Thomas M. Herzog	Management	For	For
1F.	Election of Director: Lydia H. Kennard	Management	For	For
1G.	Election of Director: Sara G. Lewis	Management	For	For
1H.	Election of Director: Katherine M. Sandstrom	Management	For	For
2.	Approval, on an advisory basis, of 2019 executive compensation.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2020.	Management	For	For

HIKMA PHARMACEUTICALS PLC
Security	G4576K104	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	30-Apr-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	TO RECEIVE THE ACCOUNTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019, TOGETHER WITH THE REPORTS OF THE DIRECTORS AND AUDITORS THEREON	Management	For	For
2.	TO DECLARE A FINAL DIVIDEND OF 30 CENTS PER ORDINARY SHARE IN RESPECT OF THE YEAR ENDED 31 DECEMBER 2019	Management	For	For
3.	TO RE-APPOINT PRICEWATERHOUSECOOPERS LLP AS AUDITORS OF THE COMPANY	Management	For	For
4.	TO AUTHORISE THE AUDIT COMMITTEE TO DETERMINE THE AUDITORS' REMUNERATION	Management	For	For
5.	TO ELECT CYNTHIA SCHWALM AS A DIRECTOR OF THE COMPANY	Management	For	For
6.	TO RE-ELECT SAID DARWAZAH AS A DIRECTOR OF THE COMPANY	Management	For	For
7.	TO RE-ELECT SIGGI OLAFSSON AS A DIRECTOR OF THE COMPANY	Management	For	For
8.	TO RE-ELECT MAZEN DARWAZAH AS A DIRECTOR OF THE COMPANY	Management	For	For
9.	TO RE-SET ROBERT PICKERING AS A DIRECTOR OF THE COMPANY	Management	For	For
10.	TO RE-ELECT ALI AL-HUSRY AS A DIRECTOR OF THE COMPANY	Management	For	For
11.	TO RE-ELECT PATRICK BUTLER AS A DIRECTOR OF THE COMPANY	Management	For	For
12.	TO RE-ELECT DR. PAMELA KIRBY AS A DIRECTOR OF THE COMPANY	Management	For	For
13.	TO RE-ELECT DR. JOCHEN GANN AS A DIRECTOR OF THE COMPANY	Management	For	For
14.	TO RE-ELECT JOHN CASTELLANI AS A DIRECTOR OF THE COMPANY	Management	For	For
15.	TO RE-ELECT NINA HENDERSON AS A DIRECTOR OF THE COMPANY	Management	For	For
16.	TO APPROVE THE DIRECTOR'S REMUNERATION POLICY, AS SET OUT ON PAGES 79-85 OF THE ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2019	Management	For	For
17.	TO RECEIVE AND APPROVE THE REMUNERATION COMMITTEE REPORT FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019	Management	For	For
18.	AUTHORISE DIRECTORS TO ALLOT SHARES UP TO AN AGGREGATE NOMINAL AMOUNT OF GBP 8,077,634	Management	For	For
19.	THAT SUBJECT TO PASSING RESOLUTION 18 ABOVE, THE DIRECTORS BE EMPOWERED TO ALLOT EQUITY SECURITIES FOR CASH ON A NON PRE-EMPTIVE BASIS UP TO THE AGGREGATE NOMINAL AMOUNT OF GBP 1,211,645	Management	For	For
20.	THAT SUBJECT TO THE PASSING OF RESOLUTION 18, THE AUTHORITY UNDER RESOLUTION 19 BE FURTHER EXTENDED TO AN AGGREGATE NOMINAL AMOUNT OF GBP 1,211,645 TO BE USED ONLY FOR THE PURPOSES OF FINANCING A TRANSACTION WHICH IS DETERMINED TO BE AN ACQUISITION OR OTHER CAPITAL INVESTMENT	Management	For	For
21.	GRANT AUTHORITY TO MAKE MARKET PURCHASES OF OWN SHARES, UP TO GBP 2,423,290 REPRESENTING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY	Management	For	For
22.	THAT A GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY OTHER THAN AN ANNUAL GENERAL MEETING MAY BE CALLED ON NOT LESS THAN 14 CLEAR DAYS' NOTICE	Management	For	For

HOLOGIC, INC.
Security	436440101	Meeting Type	Annual
Ticker Symbol	HOLX	Meeting Date	05-Mar-2020
Record Date	08-Jan-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Stephen P. MacMillan		For	For
		2	Sally W. Crawford		For	For
		3	Charles J. Dockendorff		For	For
		4	Scott T. Garrett		For	For
		5	Ludwig N. Hantson		For	For
		6	Namal Nawana		For	For
		7	Christiana Stamoulis		For	For
		8	Amy M. Wendell		For	For
2.	A non-binding advisory resolution to approve executive compensation.			Management	For	For
3.	Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2020.			Management	For	For

HOYA CORPORATION
Security	J22848105	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	24-Jun-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1.1	Appoint a Director Uchinaga, Yukako	Management	For	For
1.2	Appoint a Director Urano, Mitsudo	Management	For	For
1.3	Appoint a Director Takasu, Takeo	Management	For	For
1.4	Appoint a Director Kaihori, Shuzo	Management	For	For
1.5	Appoint a Director Yoshihara, Hiroaki	Management	For	For
1.6	Appoint a Director Suzuki, Hiroshi	Management	For	For

HUMANA INC.
Security	444859102	Meeting Type	Annual
Ticker Symbol	HUM	Meeting Date	23-Apr-2020
Record Date	24-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kurt J. Hilzinger	Management	For	For
1B.	Election of Director: Frank J. Bisignano	Management	For	For
1C.	Election of Director: Bruce D. Broussard	Management	For	For
1D.	Election of Director: Frank A. D'Amelio	Management	For	For
1E.	Election of Director: W. Roy Dunbar	Management	For	For
1F.	Election of Director: Wayne A. I. Frederick, M.D.	Management	For	For
1G.	Election of Director: John W. Garratt	Management	For	For
1H.	Election of Director: David A. Jones, Jr.	Management	For	For
1I.	Election of Director: Karen W. Katz	Management	For	For
1J.	Election of Director: William J. McDonald	Management	For	For
1K.	Election of Director: James J. O'Brien	Management	For	For
1L.	Election of Director: Marissa T. Peterson	Management	For	For
2.	The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.	Management	For	For
3.	Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2020 proxy statement.	Management	For	For

IDEXX LABORATORIES, INC.
Security	45168D104	Meeting Type	Annual
Ticker Symbol	IDXX	Meeting Date	06-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Rebecca M. Henderson, PhD	Management	For	For
1B.	Election of Director: Lawrence D. Kingsley	Management	For	For
1C.	Election of Director: Sophie V. Vandebroek, PhD	Management	For	For
2.	Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two).	Management	For	For
3.	Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).	Management	For	For

ILLUMINA, INC.
Security	452327109	Meeting Type	Annual
Ticker Symbol	ILMN	Meeting Date	27-May-2020
Record Date	30-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Caroline Dorsa	Management	For	For
1B.	Election of Director: Robert S. Epstein, M.D.	Management	For	For
1C.	Election of Director: Scott Gottlieb, M.D.	Management	For	For
1D.	Election of Director: Philip W. Schiller	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2021.	Management	For	For
3.	To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.	Management	For	For
4.	To approve, on an advisory basis, a stockholder proposal regarding political disclosures.	Shareholder	Against	For

ILLUMINOSS MEDICAL, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	1-Jul-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Amendment to Sixth Amended and Restated Certification of Incorporation	Management	For	For
2.	Amendment No. 5 to Amended and Restated Secured Note and Warrant Purchase Agreement	Management	For	For
3.	General Authorizing Resolution	Management	For	For

ILLUMINOSS MEDICAL, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	21-Apr-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Merger; Agreement and Plan of Merger	Management	For	For
2.	General Ratification and Authorization	Management	For	For

INCYTE CORPORATION
Security	45337C102	Meeting Type	Annual
Ticker Symbol	INCY	Meeting Date	26-May-2020
Record Date	01-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Julian C. Baker	Management	For	For
1.2	Election of Director: Jean-Jacques Bienaimé	Management	For	For
1.3	Election of Director: Paul J. Clancy	Management	For	For
1.4	Election of Director: Wendy L. Dixon	Management	For	For
1.5	Election of Director: Jacqualyn A. Fouse	Management	For	For
1.6	Election of Director: Paul A. Friedman	Management	For	For
1.7	Election of Director: Edmund P. Harrigan	Management	For	For
1.8	Election of Director: Katherine A. High	Management	For	For
1.9	Election of Director: Hervé Hoppenot	Management	For	For
2.	To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.	Management	For	For
3.	To approve an amendment to the Company's 1997 Employee Stock Purchase Plan.	Management	For	For
4.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2020.	Management	For	For
5.	To vote on a stockholder proposal, if properly presented, described in more detail in the proxy statement.	Shareholder	Against	For

INNATE PHARMA SA
Security	F5277D100	Meeting Type	MIX
Ticker Symbol	N/A	Meeting Date	19-May-2020
Record Date	14-May-2020

Item	Proposal	Proposed by	Vote	For/Against Management
O.1	APPROVAL OF THE CORPORATE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019	Management	For	For
O.2	APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019	Management	For	For
O.3	ALLOCATION OF INCOME FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2019 - ACKNOWLEDGEMENT THAT NO DIVIDEND HAS BEEN DISTRIBUTED FOR THE THREE PAST FINANCIAL YEARS	Management	For	For
O.4	REGULATED AGREEMENTS AND COMMITMENTS	Management	For	For
O.5	RENEWAL OF THE TERM OF OFFICE OF DELOITTE & ASSOCIES AS PRINCIPAL STATUTORY AUDITOR	Management	For	For
O.6	APPOINTMENT OF MRS. PASCALE BOISSEL AS MEMBER OF THE SUPERVISORY BOARD	Management	For	For
O.7	RENEWAL OF THE TERM OF OFFICE OF MR. OLIVIER MARTINEZ AS CENSOR OF THE BOARD OF DIRECTORS	Management	For	For
O.8	DETERMINATION OF THE COMPENSATION, MENTIONED IN ARTICLE L.225-83 OF THE FRENCH COMMERCIAL CODE, TO BE ALLOCATED TO MEMBERS OF THE SUPERVISORY BOARD	Management	For	For
O.9	APPROVAL OF THE GENERAL PRINCIPLES OF THE COMPENSATION POLICY FOR CORPORATE OFFICERS IN RESPECT OF THE FINANCIAL YEAR 2020	Management	For	For
O.10	APPROVAL OF THE COMPENSATION POLICY FOR THE CHAIRMAN OF THE MANAGEMENT BOARD IN RESPECT OF THE FINANCIAL YEAR 2020	Management	For	For
O.11	APPROVAL OF THE COMPENSATION POLICY FOR MEMBERS OF THE MANAGEMENT BOARD (EXCLUDING THE CHAIRMAN OF THE MANAGEMENT BOARD) IN RESPECT OF THE FINANCIAL YEAR 2020	Management	For	For
O.12	APPROVAL OF THE COMPENSATION POLICY FOR THE CHAIRMAN OF THE SUPERVISORY BOARD IN RESPECT OF THE FINANCIAL YEAR 2020	Management	For	For
O.13	APPROVAL OF THE COMPENSATION POLICY FOR MEMBERS OF THE SUPERVISORY BOARD (EXCLUDING THE CHAIRMAN OF THE SUPERVISORY BOARD) IN RESPECT OF THE FINANCIAL YEAR 2020	Management	For	For
O.14	APPROVAL OF ALL THE ELEMENTS OF COMPENSATION AND BENEFITS PAID OR ALLOCATED TO THE CORPORATE OFFICERS IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2019	Management	For	For
O.15	APPROVAL OF THE ELEMENTS OF COMPENSATION AND BENEFITS PAID OR ALLOCATED TO THE CHAIRMAN OF THE MANAGEMENT BOARD IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2019	Management	For	For
O.16	APPROVAL OF THE ELEMENTS OF COMPENSATION AND BENEFITS PAID OR ALLOCATED TO THE MEMBERS OF THE MANAGEMENT BOARD (EXCLUDING THE CHAIRMAN OF THE MANAGEMENT BOARD) IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2019	Management	For	For
O.17	APPROVAL OF THE ELEMENTS OF COMPENSATION AND BENEFITS PAID OR ALLOCATED TO THE CHAIRMAN OF THE SUPERVISORY BOARD IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2019	Management	For	For
O.18	AUTHORIZATION FOR THE COMPANY TO BUY BACK ITS OWN SHARES	Management	For	For
E.19	AUTHORIZATION GRANTED TO THE MANAGEMENT BOARD TO GRANT SHARE SUBSCRIPTION AND/OR SHARE PURCHASE OPTIONS TO EMPLOYEES OF INNATE PHARMA INC. SUBSIDIARY OF THE COMPANY	Management	For	For
E.20	AUTHORIZATION GRANTED TO THE MANAGEMENT BOARD TO PROCEED WITH FREE ALLOCATIONS OF EXISTING SHARES OR SHARES TO BE ISSUED TO SALARIED MEMBERS OF THE EXECUTIVE COMMITTEE, SALARIED SENIOR MANAGERS AND/OR CORPORATE OFFICERS OF THE COMPANY OR ITS SUBSIDIARIES IN RESPECT OF THEIR ANNUAL VARIABLE COMPENSATION	Management	For	For
E.21	AUTHORIZATION GRANTED TO THE MANAGEMENT BOARD TO PROCEED WITH FREE ALLOCATIONS OF EXISTING SHARES OR SHARES TO BE ISSUED ON THE BASIS OF THE ACHIEVEMENT OF PERFORMANCE CRITERIA IN FAVOUR SALARIED MANAGERS, SALARIED MEMBERS OF THE EXECUTIVE COMMITTEE, SALARIED SENIOR MANAGERS AND/OR CORPORATE OFFICERS OF THE COMPANY OR ITS SUBSIDIARIES	Management	For	For

E.22	AUTHORIZATION GRANTED TO THE MANAGEMENT BOARD TO PROCEED WITH FREE ALLOCATIONS OF EXISTING SHARES OR SHARES TO BE ISSUED ON THE BASIS OF THE ACHIEVEMENT OF PERFORMANCE CRITERIA IN FAVOUR OF EMPLOYEES OF THE COMPANY OR ITS SUBSIDIARIES	Management	For	For
E.23	DELEGATION OF AUTHORITY GRANTED TO THE MANAGEMENT BOARD TO ISSUE ORDINARY SHARES OF THE COMPANY AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANY'S CAPITAL, WITH RETENTION OF THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT	Management	For	For
E.24	DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE ORDINARY SHARES OF THE COMPANY AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANY'S CAPITAL, WITH CANCELLATION OF THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT, BY AN OFFER TO THE PUBLIC	Management	For	For
E.25	DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE ORDINARY SHARES OF THE COMPANY AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANY'S CAPITAL, WITH CANCELLATION OF THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT, AS PART OF AN OFFER REFERRED TO IN ARTICLE L. 411-2 1 OF THE FRENCH MONETARY AND FINANCIAL CODE	Management	For	For
E.26	SETTING OF THE ISSUE PRICE OF ORDINARY SHARES AND/OR ALL TRANSFERABLE SECURITIES GRANTING ACCESS TO THE CAPITAL, IN THE EVENT OF CANCELLATION OF THE PRE-EMPTIVE SUBSCRIPTION RIGHT, WITHIN THE ANNUAL LIMIT OF 10% OF THE CAPITAL	Management	For	For
E.27	DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE ORDINARY SHARES OF THE COMPANY AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANY'S CAPITAL, WITH CANCELLATION OF THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT IN FAVOUR OF CATEGORIES OF PERSONS	Management	For	For
E.28	AUTHORIZATION GRANTED TO THE MANAGEMENT BOARD IN CASE OF A CAPITAL INCREASE, WITH OR WITHOUT CANCELLATION OF THE SHAREHOLDERS' PRE-EMPTIVE SUBSCRIPTION RIGHT, TO INCREASE THE NUMBER OF SECURITIES TO BE ISSUED BY 15%	Management	For	For
E.29	DELEGATION OF POWERS TO THE MANAGEMENT BOARD IN ORDER TO ISSUE ORDINARY SHARES AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANY'S CAPITAL, AS CONSIDERATION FOR CONTRIBUTIONS IN KIND CONSISTING OF EQUITY SECURITIES OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE CAPITAL	Management	For	For
E.30	DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD TO ISSUE ORDINARY SHARES AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANY'S CAPITAL, IN THE EVENT OF A PUBLIC EXCHANGE OFFER INITIATED BY THE COMPANY	Management	For	For
E.31	OVERALL LIMITATION ON THE AUTHORIZATIONS PROVIDED FOR IN RESOLUTIONS NO.23 TO NO.25 AND NO.27 TO NO.30 ABOVE	Management	For	For
E.32	DELEGATION OF AUTHORITY TO THE MANAGEMENT BOARD IN ORDER TO ISSUE ORDINARY SHARES AND/OR TRANSFERABLE SECURITIES GRANTING ACCESS TO THE COMPANY'S CAPITAL IN FAVOUR OF MEMBERS OF A COMPANY SAVINGS PLAN	Management	For	For
E.33	DELEGATION OF POWERS GRANTED TO THE MANAGEMENT BOARD TO CANCEL ALL OR PART OF THE TREASURY SHARES HELD BY THE COMPANY BY VIRTUE OF THE SHARE BUY-BACK AUTHORIZATION	Management	For	For
E.34	AMENDMENT TO ARTICLE 15 IV. OF THE BY-LAWS IN ORDER TO MODIFY THE QUORUM AND THE MAJORITY OF DECISIONS OF THE MANAGEMENT BOARD	Management	For	For
E.35	POWERS TO CARRY OUT LEGAL FORMALITIES	Management	For	For

INTUITIVE SURGICAL, INC.
Security	46120E602	Meeting Type	Annual
Ticker Symbol	ISRG	Meeting Date	23-Apr-2020
Record Date	28-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Craig H. Barratt, Ph.D.	Management	For	For
1B.	Election of Director: Joseph C. Beery	Management	For	For
1C.	Election of Director: Gary S. Guthart, Ph.D.	Management	For	For
1D.	Election of Director: Amal M. Johnson	Management	For	For
1E.	Election of Director: Don R. Kania, Ph.D.	Management	For	For
1F.	Election of Director: Amy L. Ladd, M.D.	Management	For	For
1G.	Election of Director: Keith R. Leonard, Jr.	Management	For	For
1H.	Election of Director: Alan J. Levy, Ph.D.	Management	For	For
1I.	Election of Director: Jami Dover Nachtsheim	Management	For	For
1J.	Election of Director: Mark J. Rubash	Management	For	For
2.	To approve, by advisory vote, the compensation of the Company's Named Executive Officers.	Management	For	For
3.	The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
4.	To approve the Company's Amended and Restated 2010 Incentive Award Plan.	Management	For	For
5.	To approve the amendment of the Certificate of Incorporation to adopt simple majority voting provisions.	Management	For	For
6.	To approve the amendment of the Certificate of Incorporation to permit stockholders to call a special meeting.	Management	For	For

IO LIGHT HOLDINGS INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	29-Apr-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Shareholder rights	Management	For	For

IQVIA HOLDINGS INC.
Security	46266C105	Meeting Type	Annual
Ticker Symbol	IQV	Meeting Date	06-Apr-2020
Record Date	12-Feb-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Carol J. Burt		For	For
		2	Colleen A. Goggins		For	For
		3	Ronald A. Rittenmeyer		For	For
2.	An advisory (non-binding) vote to approve executive compensation.			Management	For	For
3.	The ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2020.			Management	For	For

JOHNSON & JOHNSON
Security	478160104	Meeting Type	Annual
Ticker Symbol	JNJ	Meeting Date	23-Apr-2020
Record Date	25-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Mary C. Beckerle	Management	For	For
1B.	Election Of Director: D. Scott Davis	Management	For	For
1C.	Election of Director: Ian E. L. Davis	Management	For	For
1D.	Election of Director: Jennifer A. Doudna	Management	For	For
1E.	Election of Director: Alex Gorsky	Management	For	For
1F.	Election of Director: Marillyn A. Hewson	Management	For	For
1G.	Election of Director: Hubert Joly	Management	For	For
1H.	Election of Director: Mark B. McClellan	Management	For	For
1I.	Election of Director: Anne M. Mulcahy	Management	For	For
1J.	Election of Director: Charles Prince	Management	For	For
1K.	Election of Director: A. Eugene Washington	Management	For	For
1L.	Election of Director: Mark A. Weinberger	Management	For	For
1M.	Election of Director: Ronald A. Williams	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation.	Management	For	For
3.	Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2020.	Management	For	For
4.	Amendment to the Restated Certificate of Incorporation to Permit Removal of Directors Without Cause.	Management	For	For
5.	Independent Board Chair	Shareholder	For	Against
6.	Report on Governance of Opioids-Related Risks	Shareholder	Against	For

KONINKLIJKE PHILIPS ELECTRONICS N.V.
Security	500472303	Meeting Type	Annual
Ticker Symbol	PHG	Meeting Date	30-Apr-2020
Record Date	02-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
2B.	Proposal to adopt the financial statements	Management	For
2C.	Proposal to adopt dividend	Management	For
2D.	Remuneration Report 2019 (advisory vote)	Management	For
2E.	Proposal to discharge the members of the Board of Management	Management	For
2F.	Proposal to discharge the members of the Supervisory Board	Management	For
3A.	Proposal to adopt a Remuneration Policy for the Board of Management	Management	For
3B.	Proposal to approve a Long-Term Incentive Plan for the Board of Management	Management	For
3C.	Proposal to adopt a Remuneration Policy for the Supervisory Board	Management	For
4A.	Proposal to re-appoint Ms N. Dhawan as member of the Supervisory Board	Management	For
4B.	Proposal to appoint Mr F. Sijbesma as member of the Supervisory Board	Management	For
4C.	Proposal to appoint Mr P. Löscher as member of the Supervisory Board	Management	For
5A.	Proposals to authorize the Board of Management to: issue shares or grant rights to acquire shares	Management	For
5B.	Proposals to authorize the Board of Management to: restrict or exclude preemption rights	Management	For
6.	Proposal to authorize the Board of Management to acquire shares in the company	Management	For
7.	Proposal to cancel shares	Management	For

KONINKLIJKE PHILIPS ELECTRONICS N.V.
Security	500472303	Meeting Type	Annual
Ticker Symbol	PHG	Meeting Date	26-Jun-2020
Record Date	29-May-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Proposal to adopt a dividend of EUR 0.85 per common share, in shares only, against the net income for 2019.	Management	For	For

LABORATORY CORP. OF AMERICA HOLDINGS
Security	50540R409	Meeting Type	Annual
Ticker Symbol	LH	Meeting Date	13-May-2020
Record Date	25-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kerrii B. Anderson	Management	For	For
1B.	Election of Director: Jean-Luc Bélingard	Management	For	For
1C.	Election of Director: Jeffrey A. Davis	Management	For	For
1D.	Election of Director: D. Gary Gilliland, M.D., Ph.D.	Management	For	For
1E.	Election of Director: Garheng Kong, M.D., Ph.D.	Management	For	For
1F.	Election of Director: Peter M. Neupert	Management	For	For
1G.	Election of Director: Richelle P. Parham	Management	For	For
1H.	Election of Director: Adam H. Schechter	Management	For	For
1I.	Election of Director: R. Sanders Williams, M.D.	Management	For	For
2.	To approve, by non-binding vote, executive compensation.	Management	For	For
3.	Ratification of the appointment of PricewaterhouseCoopers LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for 2020.	Management	For	For
4.	Shareholder proposal seeking the power for shareholders of 10% or more of our common stock to call a special shareholder meeting.	Shareholder	Against	For

LONZA GROUP AG
Security	H50524133	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	28-Apr-2020
Record Date	14-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1	ANNUAL REPORT, CONSOLIDATED FINANCIAL STATEMENTS AND FINANCIAL STATEMENTS OF LONZA	Management	For	For
2	CONSULTATIVE VOTE ON THE REMUNERATION REPORT	Management	For	For
3	DISCHARGE OF THE MEMBERS OF THE BOARD OF DIRECTORS AND THE EXECUTIVE COMMITTEE	Management	For	For
4	APPROPRIATION OF AVAILABLE EARNINGS / RESERVES FROM CAPITAL CONTRIBUTION	Management	For	For
5.1.A	RE-ELECTION TO THE BOARD OF DIRECTOR: WERNER BAUER	Management	For	For
5.1.B	RE-ELECTION TO THE BOARD OF DIRECTOR: ALBERT M. BAEHNY	Management	For	For
5.1.C	RE-ELECTION TO THE BOARD OF DIRECTOR: ANGELICA KOHLMANN	Management	For	For
5.1.D	RE-ELECTION TO THE BOARD OF DIRECTOR: CHRISTOPH MAEDER	Management	For	For
5.1.E	RE-ELECTION TO THE BOARD OF DIRECTOR: BARBARA RICHMOND	Management	For	For
5.1.F	RE-ELECTION TO THE BOARD OF DIRECTOR: JUERGEN STEINEMANN	Management	For	For
5.1.G	RE-ELECTION TO THE BOARD OF DIRECTOR: OLIVIER VERSCHEURE	Management	For	For
5.2.A	ELECTION TO THE BOARD OF DIRECTOR: DOROTHEE DEURING	Management	For	For
5.2.B	ELECTION TO THE BOARD OF DIRECTOR: MONCEF SLAOUI	Management	For	For
5.3	RE-ELECTION OF THE CHAIRMAN OF THE BOARD OF DIRECTOR: ALBERT M. BAEHNY	Management	For	For
5.4.A	RE-ELECTION TO THE NOMINATION AND COMPENSATION COMMITTEE: ANGELICA KOHLMANN	Management	For	For
5.4.B	RE-ELECTION TO THE NOMINATION AND COMPENSATION COMMITTEE: CHRISTOPH MAEDER	Management	For	For
5.4.C	RE-ELECTION TO THE NOMINATION AND COMPENSATION COMMITTEE: JUERGEN STEINEMANN	Management	For	For
6	RE-ELECTION OF THE AUDITORS: KPMG LTD, ZURICH (CH)	Management	For	For
7	ELECTION OF THE INDEPENDENT PROXY: THOMANNFISCHER, ATTORNEYS AT LAW AND NOTARIES, ELISABETHENSTRASSE 30, 4010 BASEL, SWITZERLAND, AS THE INDEPENDENT PROXY FOR A ONE-YEAR TERM UNTIL COMPLETION OF THE ANNUAL GENERAL MEETING 2021	Management	For	For
8	COMPENSATION OF THE BOARD OF DIRECTORS	Management	For	For
9.1	MAXIMUM AGGREGATE AMOUNT OF FIXED COMPENSATION OF THE EXECUTIVE COMMITTEE	Management	For	For
9.2	AGGREGATE AMOUNT OF VARIABLE SHORT-TERM COMPENSATION OF THE EXECUTIVE COMMITTEE	Management	For	For
9.3	MAXIMUM AGGREGATE AMOUNT OF VARIABLE LONG-TERM COMPENSATION OF THE EXECUTIVE COMMITTEE	Management	For	For
10	IN THE EVENT OF ANY YET UNKNOWN NEW OR MODIFIED PROPOSAL BY A SHAREHOLDER DURING THE ANNUAL GENERAL MEETING, I INSTRUCT THE INDEPENDENT REPRESENTATIVE TO VOTE AS FOLLOWS (YES = VOTE IN FAVOR OF ANY SUCH YET UNKONWN PROPOSAL; NO = VOTE AGAINST ANY SUCH YET UNKNOWN PORPOSAL; ABSTAIN)	Shareholder	Against	For

LTC PROPERTIES, INC.
Security	502175102	Meeting Type	Annual
Ticker Symbol	LTC	Meeting Date	27-May-2020
Record Date	13-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director to hold office until the 2021 Annual Meeting: Boyd W. Hendrickson	Management	For	For
1.2	Election of Director to hold office until the 2021 Annual Meeting: James J. Pieczynski	Management	For	For
1.3	Election of Director to hold office until the 2021 Annual Meeting: Devra G. Shapiro	Management	For	For
1.4	Election of Director to hold office until the 2021 Annual Meeting: Wendy L. Simpson	Management	For	For
1.5	Election of Director to hold office until the 2021 Annual Meeting: Timothy J. Triche, M.D.	Management	For	For
2.	Ratification of independent registered public accounting firm.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For

MALLINCKRODT PLC
Security	G5785G107	Meeting Type	Annual
Ticker Symbol	MNK	Meeting Date	13-May-2020
Record Date	13-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: J. Martin Carroll	Management	For	For
1B.	Election of Director: Paul R. Carter	Management	For	For
1C.	Election of Director: David Y. Norton	Management	For	For
1D.	Election of Director: Carlos V. Paya, M.D.	Management	For	For
1E.	Election of Director: JoAnn A. Reed	Management	For	For
1F.	Election of Director: Angus C. Russell	Management	For	For
1G.	Election of Director: Mark C. Trudeau	Management	For	For
1H.	Election of Director: Anne C. Whitaker	Management	For	For
1I.	Election of Director: Kneeland C. Youngblood, M.D.	Management	For	For
2.	Approve, in a non-binding vote, the re-appointment of the independent auditors and authorize, in a binding vote, the Audit Committee to set the auditors' remuneration.	Management	For	For
3.	Advisory vote to approve the Company's executive compensation.	Management	For	For
4.	Advisory vote relating to the frequency of future advisory votes to approve the Company's executive compensation.	Management	1 Year	For
5.	Approve the Board's authority to issue shares.	Management	For	For
6.	Authorize the Company and/or any subsidiary of the Company to make market purchases or overseas market purchases of Company shares.	Management	For	For
7.	Approve the change of name of the Company (Special Resolution).	Management	For	For
8.	Approve the waiver of pre-emption rights (Special Resolution).	Management	For	For
9.	Authorize the price range at which the Company can re- allot shares that it holds as treasury shares (Special Resolution).	Management	For	For
10.	Election of NOMINEE David R. Carlucci as a Director	Management	For	For

MCKESSON CORPORATION
Security	58155Q103	Meeting Type	Annual
Ticker Symbol	MCK	Meeting Date	31-Jul-2019
Record Date	04-Jun-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director for a one-year term: Dominic J. Caruso	Management	For	For
1b.	Election of Director for a one-year term: N. Anthony Coles, M.D.	Management	For	For
1c.	Election of Director for a one-year term: M. Christine Jacobs	Management	For	For
1d.	Election of Director for a one-year term: Donald R. Knauss	Management	For	For
1e.	Election of Director for a one-year term: Marie L. Knowles	Management	For	For
1f.	Election of Director for a one-year term: Bradley E. Lerman	Management	For	For
1g.	Election of Director for a one-year term: Edward A. Mueller	Management	For	For
1h.	Election of Director for a one-year term: Susan R. Salka	Management	For	For
1i.	Election of Director for a one-year term: Brian S. Tyler	Management	For	For
1j.	Election of Director for a one-year term: Kenneth E. Washington	Management	For	For
2.	Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2020.	Management	For	For
3.	Advisory vote on executive compensation.	Management	For	For
4.	Shareholder proposal on disclosure of lobbying activities and expenditures.	Shareholder	Against	For
5.	Shareholder proposal on 10% ownership threshold for calling special meetings of shareholders.	Shareholder	Against	For

MEDICAL PROPERTIES TRUST, INC.
Security	58463J304	Meeting Type	Annual
Ticker Symbol	MPW	Meeting Date	21-May-2020
Record Date	20-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Edward K. Aldag, Jr.	Management	For	For
1B.	Election of Director: G. Steven Dawson	Management	For	For
1C.	Election of Director: R. Steven Hamner	Management	For	For
1D.	Election of Director: Caterina A. Mozingo	Management	For	For
1E.	Election of Director: Elizabeth N. Pitman	Management	For	For
1F.	Election of Director: C. Reynolds Thompson, III	Management	For	For
1G.	Election of Director: D. Paul Sparks, Jr.	Management	For	For
1H.	Election of Director: Michael G. Stewart	Management	For	For
2.	To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
3.	Non-binding, advisory approval of the Company's executive compensation.	Management	For	For

MEDTRONIC PLC
Security	G5960L103	Meeting Type	Annual
Ticker Symbol	MDT	Meeting Date	06-Dec-2019
Record Date	10-Oct-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Richard H. Anderson	Management	For	For
1B.	Election of Director: Craig Arnold	Management	For	For
1C.	Election of Director: Scott C. Donnelly	Management	For	For
1D.	Election of Director: Andrea J. Goldsmith, Ph.D.	Management	For	For
1E.	Election of Director: Randall J. Hogan, III	Management	For	For
1F.	Election of Director: Omar Ishrak	Management	For	For
1G.	Election of Director: Michael O. Leavitt	Management	For	For
1H.	Election of Director: James T. Lenehan	Management	For	For
1I.	Election of Director: Geoffrey S. Martha	Management	For	For
1J.	Election of Director: Elizabeth G. Nabel, M.D.	Management	For	For
1K.	Election of Director: Denise M. O'Leary	Management	For	For
1L.	Election of Director: Kendall J. Powell	Management	For	For
2.	To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as Medtronic's independent auditor for fiscal year 2020 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.	Management	For	For
3.	To approve, in a non-binding advisory vote, named executive officer compensation (a "Say-on-Pay" vote).	Management	For	For
4.	To renew the Board's authority to issue shares.	Management	For	For
5.	To renew the Board's authority to opt out of pre-emption rights.	Management	For	For
6.	Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.	Management	For	For

MERCK & CO., INC.
Security	58933Y105	Meeting Type	Annual
Ticker Symbol	MRK	Meeting Date	26-May-2020
Record Date	27-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Leslie A. Brun	Management	For	For
1B.	Election of Director: Thomas R. Cech	Management	For	For
1C.	Election of Director: Mary Ellen Coe	Management	For	For
1D.	Election of Director: Pamela J. Craig	Management	For	For
1E.	Election of Director: Kenneth C. Frazier	Management	For	For
1F.	Election of Director: Thomas H. Glocer	Management	For	For
1G.	Election of Director: Risa Lavizzo-Mourey	Management	For	For
1H.	Election of Director: Paul B. Rothman	Management	For	For
1I.	Election of Director: Patricia F. Russo	Management	For	For
1J.	Election of Director: Christine E. Seidman	Management	For	For
1K.	Election of Director: Inge G. Thulin	Management	For	For
1L.	Election of Director: Kathy J. Warden	Management	For	For
1M.	Election of Director: Peter C. Wendell	Management	For	For
2.	Non-binding advisory vote to approve the compensation of our named executive officers.	Management	For	For
3.	Ratification of the appointment of the Company's independent registered public accounting firm for 2020.	Management	For	For
4.	Shareholder proposal concerning shareholder right to act by written consent.	Shareholder	Against	For
5.	Shareholder proposal regarding allocation of corporate tax savings.	Shareholder	Against	For

METTLER-TOLEDO INTERNATIONAL INC.
Security	592688105	Meeting Type	Annual
Ticker Symbol	MTD	Meeting Date	07-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Robert F. Spoerry	Management	For	For
1.2	Election of Director: Wah-Hui Chu	Management	For	For
1.3	Election of Director: Domitille Doat-Le Bigot	Management	For	For
1.4	Election of Director: Olivier A. Filliol	Management	For	For
1.5	Election of Director: Elisha W. Finney	Management	For	For
1.6	Election of Director: Richard Francis	Management	For	For
1.7	Election of Director: Michael A. Kelly	Management	For	For
1.8	Election of Director: Thomas P. Salice	Management	For	For
2.	RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	Management	For	For
3.	ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION.	Management	For	For

MORPHOSYS AG
Security	617760202	Meeting Type	Annual
Ticker Symbol	MOR	Meeting Date	27-May-2020
Record Date	17-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
2.	Resolution on the discharge of Management Board members for the 2019 financial year	Management	For	For
3.	Resolution on the discharge of Supervisory Board members for the 2019 financial year	Management	For	For
4.	Resolution on the appointment of the auditor for the 2020 financial year	Management	For	For
5.	Resolution on the reduction of the number of Supervisory Board members; amendment to the Articles of Association	Management	For	For
6A.	Election of Supervisory Board member: Ms. Wendy Johnson Profession: Managing Director, Gemini Advisors, San Diego, California, USA, and Chief Operating Officer at Reneo Pharmaceuticals, Inc., San Diego, California, USA Residence: San Diego, California, USA	Management	For	For
6B.	Election of Supervisory Board member: Dr. George Golumbeski Profession: Freelance business consultant in the life sciences and healthcare industries Residence: Far Hills, New Jersey, USA	Management	For	For
6C.	Election of Supervisory Board member: Mr. Michael Brosnan Profession: Freelance business consultant in the life sciences and healthcare industries Residence: Westford, Massachusetts, USA	Management	For	For
7.	Resolution on an additional amendment to the Articles of Association with regard to the prerequisites for participation in the Annual General Meeting	Management	For	For
8.	Resolution on a further amendment to the Articles of Association with regard to conducting the Annual General Meeting	Management	For	For
9.	Resolution on the adjustment of Supervisory Board remuneration	Management	For	For
10.	Resolution on the cancellation of Authorized Capital 2017-I and the creation of new Authorized Capital 2020-I with the option to exclude statutory subscription rights; changes in the Articles of Association	Management	For	For
11.	Resolution on the creation of Conditional Capital 2020-I and the authorization to grant subscription rights to members of the Management Board of MorphoSys AG, members of the executive management bodies of affiliated companies in Germany and abroad and selected employees of MorphoSys AG and affiliated companies in Germany and abroad (Stock Option Plan 2020); amendment of the Articles of Association	Management	For	For

MYLAN N.V.
Security	N59465109	Meeting Type	Special
Ticker Symbol	MYL	Meeting Date	15-Jun-2020
Record Date	05-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the Combination Proposal: (A) Approval of the Mylan Merger; (B) Approval of the Share Sale; (C) Approval of the Mylan Newco Liquidation; (D) Approval of the Alternative Transaction Structure; and (E) Approval of the Discharge of Directors (in each case with the foregoing capitalized terms as defined in the accompanying proxy statement).	Management	For	For
2.	Adoption of a non-binding, advisory resolution to adopt the compensation that will or may be paid or become payable to Mylan's named executive officers in connection with, or following, the consummation of the Combination as described in the proxy statement.	Management	For	For
3.	Adoption of a non-binding, advisory resolution to adopt certain features of Newco's governance which will replace the corresponding features of Mylan's governance, effective upon the closing of the Combination, relating to (i) the right of stockholders to nominate directors and make other stockholder proposals at stockholder meetings and (ii) director terms and stockholder removal of directors.	Management	For	For
4.	Adoption of a non-binding, advisory resolution to adopt certain features of Newco's governance which will replace the corresponding features of Mylan's governance, effective upon the closing of the Combination, relating to the right of stockholders to call special meetings of stockholders.	Management	For	For

MYLAN N.V.
Security	N59465109	Meeting Type	Special
Ticker Symbol	MYL	Meeting Date	30-Jun-2020
Record Date	02-Jun-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Appointment of the Director: Heather Bresch	Management	For	For
1B.	Appointment of the Director: Hon. Robert J. Cindrich	Management	For	For
1C.	Appointment of the Director: Robert J. Coury	Management	For	For
1D.	Appointment of the Director: JoEllen Lyons Dillon	Management	For	For
1E.	Appointment of the Director: Neil Dimick, C.P.A.	Management	For	For
1F.	Appointment of the Director: Melina Higgins	Management	For	For
1G.	Appointment of the Director: Harry A. Korman	Management	For	For
1H.	Appointment of the Director: Rajiv Malik	Management	For	For
1I.	Appointment of the Director: Richard Mark, C.P.A.	Management	For	For
1J.	Appointment of the Director: Mark W. Parrish	Management	For	For
1K.	Appointment of the Director: Pauline van der Meer Mohr	Management	For	For
1L.	Appointment of the Director: Randall L. (Pete) Vanderveen, Ph.D.	Management	For	For
1M.	Appointment of the Director: Sjoerd S. Vollebregt	Management	For	For
2.	Approval, on an advisory basis, of the compensation of the named executive officers of the Company.	Management	For	For
3.	Adoption of the Dutch annual accounts for fiscal year 2019.	Management	For	For
4.	Ratification of the selection of Deloitte & Touche LLP as Mylan's independent registered public accounting firm for fiscal year 2020.	Management	For	For
5.	Instruction to Deloitte Accountants B.V. for the audit of Mylan's Dutch statutory annual accounts for fiscal year 2020.	Management	For	For
6.	Authorization of the Board to acquire shares in the capital of the Company.	Management	For	For
7.	Delegation to the Board of the authority to issue ordinary shares and grant rights to subscribe for ordinary shares in the capital of the Company and to exclude or restrict pre-emptive rights.	Management	For	For
E1E	Approval of the Combination Proposal. ...(due to space limits, see proxy material for full proposal).	Management	For	For
E2E	Adoption of a non-binding, advisory resolution to adopt the compensation that will or may be paid or become payable to Mylan's named executive officers in connection with, or following, the consummation of the Combination as described in the proxy statement.	Management	For	For
E3E	Adoption of a non-binding, advisory resolution to adopt certain features of Newco's governance which will replace the corresponding features of Mylan's governance, effective upon the closing of the Combination, relating to (i) the right of stockholders to nominate directors and make other stockholder proposals at stockholder meetings and (ii) director terms and stockholder removal of directors.	Management	For	For
E4E	Adoption of a non-binding, advisory resolution to adopt certain features of Newco's governance which will replace the corresponding features of Mylan's governance, effective upon the closing of the Combination, relating to the right of stockholders to call special meetings of stockholders.	Management	For	For

NATIONAL HEALTH INVESTORS, INC.
Security	63633D104	Meeting Type	Annual
Ticker Symbol	NHI	Meeting Date	06-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: W. Andrew Adams	Management	For	For
1B.	Election of Director: Robert A. McCabe, Jr.	Management	For	For
1C.	Election of Director: Charlotte A. Swafford	Management	For	For
1D.	Election of Director: Robert G. Adams	Management	For	For
2.	Approve the Amendment to the Articles of Incorporation to increase the number of authorized shares.	Management	For	For
3.	Approve the advisory resolution approving the compensation of the named executive officers as disclosed in the accompanying proxy statement.	Management	For	For
4.	Ratify the audit committee's selection of BDO USA, LLP as independent registered public accounting firm for year ending December 31, 2020.	Management	For	For

NEKTAR THERAPEUTICS
Security	640268108	Meeting Type	Annual
Ticker Symbol	NKTR	Meeting Date	17-Jun-2020
Record Date	20-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Karin Eastham	Management	For	For
1B.	Election of Director: Myriam J. Curet	Management	For	For
1C.	Election of Director: Howard W. Robin	Management	For	For
2.	To approve an amendment of our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 10,000,000 shares.	Management	For	For
3.	To approve an amendment and restatement of our Amended and Restated Employee Stock Purchase Plan to increase the aggregate number of shares of common stock authorized under the plan by 1,000,000 shares.	Management	For	For
4.	To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
5.	To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote).	Management	For	For

NEW SENIOR INVESTMENT GROUP INC.
Security	648691103	Meeting Type	Annual
Ticker Symbol	SNR	Meeting Date	28-May-2020
Record Date	03-Apr-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Stuart A. McFarland		For	For
		2	Robert F. Savage		For	For
2.	Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for New Senior Investment Group Inc. for fiscal year 2020.			Management	For	For
3.	Approval of an advisory vote on 2019 executive compensation.			Management	For	For
4.	Approval of an advisory vote on the frequency of future advisory votes on executive compensation.			Management	1 Year	For
5.	Approval of amendments to our Certificate of Incorporation and Bylaws to provide for the annual election of all directors.			Management	For	For
6.	Approval of amendments to our Bylaws to implement majority voting in uncontested director elections.			Management	For	For
7A.	Approval of an amendment to our Certificate of Incorporation to eliminate the supermajority voting requirement to amend certain provisions of our Certificate of Incorporation.			Management	For	For
7B.	Approval of amendments to our Certificate of Incorporation and Bylaws to eliminate the supermajority voting requirements to amend our Bylaws.			Management	For	For
7C.	Approval of amendments to our Certificate of Incorporation and Bylaws to eliminate the supermajority voting requirements to remove directors for cause and appoint directors in the event the entire Board of Directors is removed.			Management	For	For

NOVARTIS AG
Security	66987V109	Meeting Type	Annual
Ticker Symbol	NVS	Meeting Date	28-Feb-2020
Record Date	23-Jan-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the Operating and Financial Review of Novartis AG, the Financial Statements of Novartis AG and the Group Consolidated Financial Statements for the 2019 Financial Year.	Management	For	For
2.	Discharge from Liability of the Members of the Board of Directors and the Executive Committee.	Management	For	For
3.	Appropriation of Available Earnings of Novartis AG as per Balance Sheet and Declaration of Dividend for 2019.	Management	For	For
4.	Reduction of Share Capital.	Management	For	For
5A.	Binding Vote on the Maximum Aggregate Amount of Compensation for the Board of Directors from the 2020 Annual General Meeting to the 2021 Annual General Meeting.	Management	For	For
5B.	Binding Vote on the Maximum Aggregate Amount of Compensation for the Executive Committee for the Financial Year 2021.	Management	For	For
5C.	Advisory Vote on the 2019 Compensation Report.	Management	For	For
6A.	Re-election of the Chairman and the Member of the Board of Director: Joerg Reinhardt	Management	For	For
6B.	Re-election of the Member of the Board of Director: Nancy C. Andrews	Management	For	For
6C.	Re-election of the Member of the Board of Director: Ton Buechner	Management	For	For
6D.	Re-election of the Member of the Board of Director: Patrice Bula	Management	For	For
6E.	Re-election of the Member of the Board of Director: Srikant Datar	Management	For	For
6F.	Re-election of the Member of the Board of Director: Elizabeth Doherty	Management	For	For
6G.	Re-election of the Member of the Board of Director: Ann Fudge	Management	For	For
6H.	Re-election of the Member of the Board of Director: Frans van Houten	Management	For	For
6I.	Re-election of the Member of the Board of Director: Andreas von Planta	Management	For	For
6J.	Re-election of the Member of the Board of Director: Charles L. Sawyers	Management	For	For
6K.	Re-election of the Member of the Board of Director: Enrico Vanni	Management	For	For
6L.	Re-election of the Member of the Board of Director: William T. Winters	Management	For	For
6M.	Election of new Member of the Board of Director: Bridgette Heller	Management	For	For
6N.	Election of new Member of the Board of Director: Simon Moroney	Management	For	For
7A.	Re-election to the Compensation Committee: Patrice Bula	Management	For	For
7B.	Re-election to the Compensation Committee: Srikant Datar	Management	For	For
7C.	Re-election to the Compensation Committee: Enrico Vanni	Management	For	For
7D.	Re-election to the Compensation Committee: William T. Winters	Management	For	For
7E.	Election of new Member to the Compensation Committee: Bridgette Heller	Management	For	For
8.	Re-election of the Statutory Auditor.	Management	For	For
9.	Re-election of the Independent Proxy.	Management	For	For
10.	General instructions in case of alternative motions under the agenda items published in the Notice of Annual General Meeting, and/or of motions relating to additional agenda items according to Article 700 paragraph 3 of the Swiss Code of Obligations.	Management	Abstain

NOVAVAX, INC.
Security	670002401	Meeting Type	Annual
Ticker Symbol	NVAX	Meeting Date	25-Jun-2020
Record Date	29-Apr-2020

Item	Proposal			Proposed by	Vote	For/Against Management
1.	DIRECTOR			Management
		1	Stanley C. Erck		For	For
		2	Rajiv I. Modi, Ph.D.		For	For
2.	To approve, on an advisory basis, the compensation paid to our Named Executive Officers.			Management	For	For
3.	To amend and restate the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended to increase individual and non-employee director stock award limits granted to any person in any calendar year, and to increase the number of shares of the Company's common stock, par value $0.01, available for issuance thereunder by 7,100,000 shares.			Management	For	For
4.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.			Management	For	For

OCULIS SA
Security	N/A	Meeting Type	Extraordinary General Meeting
Ticker Symbol	N/A	Meeting Date	26-Nov-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Ordinary Share Capital Increase	Management	For	For
2.	Conditional Share Capital Increase	Management	For	For

OCULIS SA
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	9-Mar-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Ordinary Share Capital Increase	Management	For	For
2.	Conditional Share Capital Increase	Management	For	For

OCULIS SA
Security	N/A	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	25-Jun-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of Annual Report including Financial Statements	Management	For	For
2.	Appropriation of Balance Sheet Result 2019	Management	For	For
3.	Discharge of the Members of the Board and Management	Management	For	For
4.	Re-Election of Board of Directors	Management	For	For
5.	Re-Election of the Auditors	Management	For	For

OMEGA HEALTHCARE INVESTORS, INC.
Security	681936100	Meeting Type	Annual
Ticker Symbol	OHI	Meeting Date	11-Jun-2020
Record Date	13-Apr-2020

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Kapila K. Anand		For	For
	2	Craig R. Callen		For	For
	3	Barbara B. Hill		For	For
	4	Edward Lowenthal		For	For
	5	C. Taylor Pickett		For	For
	6	Stephen D. Plavin		For	For
	7	Burke W. Whitman		For	For
2.	Ratification of Independent Auditors Ernst & Young LLP for fiscal year 2020.		Management	For	For
3.	Approval, on an Advisory Basis, of Executive Compensation.		Management	For	For

ONO PHARMACEUTICAL CO.,LTD.
Security	J61546115	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	18-Jun-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1.	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director Sagara, Gyo	Management	For	For
2.2	Appoint a Director Awata, Hiroshi	Management	For	For
2.3	Appoint a Director Ono, Isao	Management	For	For
2.4	Appoint a Director Tsujinaka, Toshihiro	Management	For	For
2.5	Appoint a Director Takino, Toichi	Management	For	For
2.6	Appoint a Director Kurihara, Jun	Management	For	For
2.7	Appoint a Director Nomura, Masao	Management	For	For
2.8	Appoint a Director Okuno, Akiko	Management	For	For
3.1	Appoint a Corporate Auditor Nishimura, Katsuyoshi	Management	For	For
3.2	Appoint a Corporate Auditor Hishiyama, Yasuo	Management	For	For
3.3	Appoint a Corporate Auditor Tanabe, Akiko	Management	For	For

OTSUKA HOLDINGS CO.,LTD.
Security	J63117105	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	27-Mar-2020
Record Date	31-Dec-2019

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1.1	Appoint a Director Otsuka, Ichiro	Management	For	For
1.2	Appoint a Director Higuchi, Tatsuo	Management	For	For
1.3	Appoint a Director Matsuo, Yoshiro	Management	For	For
1.4	Appoint a Director Makino, Yuko	Management	For	For
1.5	Appoint a Director Takagi, Shuichi	Management	For	For
1.6	Appoint a Director Tobe, Sadanobu	Management	For	For
1.7	Appoint a Director Kobayashi, Masayuki	Management	For	For
1.8	Appoint a Director Tojo, Noriko	Management	For	For
1.9	Appoint a Director Inoue, Makoto	Management	For	For
1.10	Appoint a Director Matsutani, Yukio	Management	For	For
1.11	Appoint a Director Sekiguchi, Ko	Management	For	For
1.12	Appoint a Director Aoki, Yoshihisa	Management	For	For
1.13	Appoint a Director Mita, Mayo	Management	For	For

PERKINELMER, INC.
Security	714046109	Meeting Type	Annual
Ticker Symbol	PKI	Meeting Date	28-Apr-2020
Record Date	28-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Peter Barrett	Management	For	For
1B.	Election of Director: Samuel R. Chapin	Management	For	For
1C.	Election of Director: Sylvie Grégoire, PharmD	Management	For	For
1D.	Election of Director: Alexis P. Michas	Management	For	For
1E.	Election of Director: Prahlad R. Singh, PhD	Management	For	For
1F.	Election of Director: Michel Vounatsos	Management	For	For
1G.	Election of Director: Frank Witney, PhD	Management	For	For
1H.	Election of Director: Pascale Witz	Management	For	For
2.	To ratify the selection of Deloitte & Touche LLP as PerkinElmer's independent registered public accounting firm for the current fiscal year.	Management	For	For
3.	To approve, by non-binding advisory vote, our executive compensation.	Management	For	For

PERRIGO COMPANY PLC
Security	G97822103	Meeting Type	Annual
Ticker Symbol	PRGO	Meeting Date	06-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Bradley A. Alford	Management	For	For
1.2	Election of Director: Rolf A. Classon	Management	For	For
1.3	Election of Director: Adriana Karaboutis	Management	For	For
1.4	Election of Director: Murray S. Kessler	Management	For	For
1.5	Election of Director: Jeffrey B. Kindler	Management	For	For
1.6	Election of Director: Erica L. Mann	Management	For	For
1.7	Election of Director: Donal O'Connor	Management	For	For
1.8	Election of Director: Geoffrey M. Parker	Management	For	For
1.9	Election of Director: Theodore R. Samuels	Management	For	For
2.	Ratify the appointment of Ernst & Young LLP as our independent auditor for the period ending December 31, 2020 and authorize the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor.	Management	For	For
3.	Advisory vote on the Company's executive compensation.	Management	For	For
4.	Renew the Board's authority to issue shares under Irish law.	Management	For	For
5.	Renew the Board's authority to opt-out of statutory pre- emption rights under Irish law.	Management	For	For

PFIZER INC.
Security	717081103	Meeting Type	Annual
Ticker Symbol	PFE	Meeting Date	23-Apr-2020
Record Date	25-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Ronald E. Blaylock	Management	For	For
1B.	Election of Director: Albert Bourla	Management	For	For
1C.	Election of Director: W. Don Cornwell	Management	For	For
1D.	Election of Director: Joseph J. Echevarria	Management	For	For
1E.	Election of Director: Scott Gottlieb	Management	For	For
1F.	Election of Director: Helen H. Hobbs	Management	For	For
1G.	Election of Director: Susan Hockfield	Management	For	For
1H.	Election of Director: James M. Kilts	Management	For	For
1I.	Election of Director: Dan R. Littman	Management	For	For
1J.	Election of Director: Shantanu Narayen	Management	For	For
1K.	Election of Director: Suzanne Nora Johnson	Management	For	For
1L.	Election of Director: James Quincey	Management	For	For
1M.	Election of Director: James C. Smith	Management	For	For
2.	Ratify the selection of KPMG LLP as independent registered public accounting firm for 2020	Management	For	For
3.	2020 advisory approval of executive compensation	Management	For	For
4.	Shareholder proposal regarding right to act by written consent	Shareholder	Against	For
5.	Shareholder proposal regarding enhancing proxy access	Shareholder	Against	For
6.	Shareholder proposal regarding report on lobbying activities	Shareholder	Against	For
7.	Shareholder proposal regarding independent chair policy	Shareholder	For	Against
8.	Shareholder proposal regarding gender pay gap	Shareholder	Against	For
9.	Election of Director: Susan Desmond-Hellmann	Management	For	For

PHYSICIANS REALTY TRUST
Security	71943U104	Meeting Type	Annual
Ticker Symbol	DOC	Meeting Date	06-May-2020
Record Date	13-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	DIRECTOR	Management
	1  John T. Thomas		For	For
	2  Tommy G. Thompson		For	For
	3  Stanton D. Anderson		For	For
	4  Mark A. Baumgartner		For	For
	5  Albert C. Black, Jr.		For	For
	6  William A Ebinger, M.D		For	For
	7  Pamela J. Kessler		For	For
	8  Richard A. Weiss		For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
3.	To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement.	Management	For	For

QUEST DIAGNOSTICS INCORPORATED
Security	74834L100	Meeting Type	Annual
Ticker Symbol	DGX	Meeting Date	19-May-2020
Record Date	20-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Vicky B. Gregg	Management	For	For
1B.	Election of Director: Wright L. Lassiter III	Management	For	For
1C.	Election of Director: Timothy L. Main	Management	For	For
1D.	Election of Director: Denise M. Morrison	Management	For	For
1E.	Election of Director: Gary M. Pfeiffer	Management	For	For
1F.	Election of Director: Timothy M. Ring	Management	For	For
1G.	Election of Director: Stephen H. Rusckowski	Management	For	For
1H.	Election of Director: Daniel C. Stanzione	Management	For	For
1I.	Election of Director: Helen I. Torley	Management	For	For
1J.	Election of Director: Gail R. Wilensky	Management	For	For
2.	An advisory resolution to approve the executive officer compensation disclosed in the Company's 2020 proxy statement	Management	For	For
3.	Ratification of the appointment of our independent registered public accounting firm for 2020	Management	For	For

RAINIER THERAPEUTICS, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	11-Jul-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Authorization and Approval of Unsecured Note Amendment and Secured Note Financing	Management	For	For
2.	Security Interest Grant to Note Recipients	Management	For	For
3.	General Authorizing Resolution	Management	For	For

RAINIER THERAPEUTICS, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	30-Oct-2019
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Adoption of Change in Control Retention Plan	Management	For	For
2.	General Authorizing Resolution	Management	For	For

RAINIER THERAPEUTICS, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	3-Mar-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Asset Purchase Agreement	Management	For	For
2.	Appointment of Seller's Representative	Management	For	For
3.	Waiver of Notice Requirement	Management	For	For
4.	Series A and Series B Stockholder Waiver	Management	For	For
5.	Interested Party Transactions	Management	For	For
6.	General Authorizing Resolution	Management	For	For

RAINIER THERAPEUTICS, INC.
Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	19-May-2020
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Adoption of Plan of Complete Liquidation, Liquidation and Dissolution	Management	For	For
2.	Interested Party Transactions	Management	For	For
3.	Waiver of Notice Requirement	Management	For	For
4.	General Authorizing Resolution	Management	For	For

REGENERON PHARMACEUTICALS, INC.
Security	75886F107	Meeting Type	Annual
Ticker Symbol	REGN	Meeting Date	12-Jun-2020
Record Date	14-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: N. Anthony Coles, M.D.	Management	For	For
1B.	Election of Director: Joseph L. Goldstein, M.D.	Management	For	For
1C.	Election of Director: Christine A. Poon	Management	For	For
1D.	Election of Director: P. Roy Vagelos, M.D.	Management	For	For
1E.	Election of Director: Huda Y. Zoghbi, M.D.	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
3.	Proposal to approve the Second Amended and Restated Regeneron Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan.	Management	For	For
4.	Proposal to approve, on an advisory basis, executive compensation.	Management	For	For

RESMED INC.
Security	761152107	Meeting Type	Annual
Ticker Symbol	RMD	Meeting Date	21-Nov-2019
Record Date	26-Sep-2019

Item	Proposal	Proposed by	Vote		For/Against Management
1A.	Election of Director: Carol Burt	Management		For	For
1B.	Election of Director: Jan De Witte	Management		For	For
1C.	Election of Director: Richard Sulpizio	Management		For	For
2.	Ratify our appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2020.	Management		For	For
3.	Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay").	Management		For	For

SABRA HEALTH CARE REIT, INC.
Security	78573L106	Meeting Type	Annual
Ticker Symbol	SBRA	Meeting Date	09-Jun-2020
Record Date	20-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Craig A. Barbarosh	Management	For	For
1B.	Election of Director: Robert A. Ettl	Management	For	For
1C.	Election of Director: Michael J. Foster	Management	For	For
1D.	Election of Director: Ronald G. Geary	Management	For	For
1E.	Election of Director: Lynne S. Katzmann	Management	For	For
1F.	Election of Director: Raymond J. Lewis	Management	For	For
1G.	Election of Director: Jeffrey A. Malehorn	Management	For	For
1H.	Election of Director: Richard K. Matros	Management	For	For
1I.	Election of Director: Milton J. Walters	Management	For	For
2.	Approval of amendments to the Sabra Health Care REIT, Inc. 2009 Performance Incentive Plan.	Management	For	For
3.	Approval of an amendment to Sabra's charter to increase the number of authorized shares of common stock, par value $0.01 per share, of Sabra from 250,000,000 to 500,000,000.	Management	For	For
4.	Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2020.	Management	For	For
5.	Approval, on an advisory basis, of the compensation of Sabra's named executive officers.	Management	For	For

SANOFI
Security	80105N105	Meeting Type	Annual
Ticker Symbol	SNY	Meeting Date	28-Apr-2020
Record Date	30-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the individual company financial statements for the year ended December 31, 2019	Management	For	For
2.	Approval of the consolidated financial statements for the year ended December 31, 2019	Management	For	For
3.	Appropriation of results for the year ended December 31, 2019 and declaration of dividend	Management	For	For
4.	Approval of regulated agreements and commitments falling within the scope of Articles L. 225-38 et seq of the French Commercial Code	Management	For	For
5.	Ratification of the co-opting of Paul Hudson as a Director	Management	For	For
6.	Reappointment of Laurent Attal as a Director	Management	For	For
7.	Reappointment of Carole Piwnica as a Director	Management	For	For
8.	Reappointment of Diane Souza as a Director	Management	For	For
9.	Reappointment of Thomas Südhof as a Director	Management	For	For
10.	Appointment of Rachel Duan as a Director	Management	For	For
11.	Appointment of Lise Kingo as a Director	Management	For	For
12.	Determination of the compensation amount for the Board of Directors	Management	For	For
13.	Approval of the compensation policy for directors	Management	For	For
14.	Approval of the compensation policy for the Chairman of the Board of Directors	Management	For	For
15.	Approval of the compensation policy for the Chief Executive Officer	Management	For	For
16.	Approval of the report on the compensation of corporate officers issued in accordance with Article L. 225-37-3 I. of the French Commercial Code	Management	For	For
17.	Approval of the components of the compensation paid or awarded in respect of the year ended 31 December 2019 to Serge Weinberg, Chairman of the Board	Management	For	For
18.	Approval of the components of the compensation paid or awarded in respect of the year ended 31 December 2019 to Paul Hudson, Chief Executive Officer from September 1, 2019	Management	For	For
19.	Approval of the components of the compensation paid or awarded in respect of the year ended 31 December 2019 to Olivier Brandicourt, Chief Executive Officer until August 31, 2019	Management	For	For
20.	Authorization to the Board of Directors to carry out transactions in the Company's shares (usable outside the period of a public tender offer)	Management	For	For
21.	Powers for formalities	Management	For	For

SHIONOGI & CO.,LTD.
Security	J74229105	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	23-Jun-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director Teshirogi, Isao	Management	For	For
2.2	Appoint a Director Sawada, Takuko	Management	For	For
2.3	Appoint a Director Ando, Keiichi	Management	For	For
2.4	Appoint a Director Ozaki, Hiroshi	Management	For	For
2.5	Appoint a Director Takatsuki, Fumi	Management	For	For
3.1	Appoint a Corporate Auditor Kato, Ikuo	Management	For	For
3.2	Appoint a Corporate Auditor Okuhara, Shuichi	Management	For	For

SMITH & NEPHEW PLC
Security	83175M205	Meeting Type	Annual
Ticker Symbol	SNN	Meeting Date	09-Apr-2020
Record Date	24-Feb-2020

Item	Proposal	Proposed by	Vote	For/Against Management
O1	To receive the audited accounts.	Management	For	For
O2	To approve the Directors' Remuneration Policy.	Management	For	For
O3	To approve the Directors' Remuneration Report (excluding policy)	Management	For	For
O4	To declare a final dividend.	Management	For	For
O5	Election/Re-Election of Director: Graham Baker	Management	For	For
O6	Election/Re-Election of Director: Vinita Bali	Management	For	For
O7	Election/Re-Election of Director: The Rt. Hon Baroness Virginia Bottomley	Management	For	For
O8	Election/Re-Election of Director: Roland Diggelmann	Management	For	For
O9	Election/Re-Election of Director: Erik Engstrom	Management	For	For
O10	Election/Re-Election of Director: Robin Freestone	Management	For	For
O11	Election/Re-Election of Director: Marc Owen	Management	For	For
O12	Election/Re-Election of Director: Angie Risley	Management	For	For
O13	Election/Re-Election of Director: Roberto Quarta	Management	For	For
O14	To re-appoint the Auditor.	Management	For	For
O15	To authorise Directors' to determine the remuneration of the Auditor.	Management	For	For
O16	To approve the Smith & Nephew Global Share Plan 2020.	Management	For	For
O17	To renew the Directors' authority to allot shares.	Management	For	For
S18	To renew the Directors' authority for the disapplication of the pre-emption rights.	Management	For	For
S19	To authorise the Directors to disapply pre-emption rights for the purposes of acquisitions or other capital investments.	Management	For	For
S20	To renew the Directors' limited authority to make market purchases of the Company's own shares.	Management	For	For
S21	To authorise general meetings to be held on 14 clear days' notice.	Management	For	For

SOSEI GROUP CORPORATION
Security	J7637L109	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	25-Mar-2020
Record Date	31-Dec-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Appoint a Director Tamura, Shinichi	Management	For	For
1.2	Appoint a Director Toyama, Tomohiro	Management	For	For
1.3	Appoint a Director Kaga, Kuniaki	Management	For	For
1.4	Appoint a Director David Roblin	Management	For	For
1.5	Appoint a Director Nagai, Noriaki	Management	For	For
1.6	Appoint a Director Rolf Soderstrom	Management	For	For

STERIS PLC
Security	G8473T100	Meeting Type	Annual
Ticker Symbol	STE	Meeting Date	30-Jul-2019
Record Date	30-May-2019

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Re-election of Director: Richard C. Breeden	Management	For	For
1b.	Re-election of Director: Cynthia L. Feldmann	Management	For	For
1c.	Re-election of Director: Dr. Jacqueline B. Kosecoff	Management	For	For
1d.	Re-election of Director: David B. Lewis	Management	For	For
1e.	Re-election of Director: Walter M Rosebrough, Jr.	Management	For	For
1f.	Re-election of Director: Dr. Nirav R. Shah	Management	For	For
1g.	Re-election of Director: Dr. Mohsen M. Sohi	Management	For	For
1h.	Re-election of Director: Dr. Richard M. Steeves	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2020.	Management	For	For
3.	To appoint Ernst & Young Chartered Accountants as the Company's Irish statutory auditor under the Act to hold office until the conclusion of the Company's next Annual General Meeting.	Management	For	For
4.	To authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company's Irish statutory auditor.	Management	For	For
5.	To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2019.	Management	For	For

STERIS PLC
Security	G8473T100	Meeting Type	Annual
Ticker Symbol	STE	Meeting Date	28-Jul-2020
Record Date	29-May-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Re-election of Director: Richard C. Breeden	Management	For	For
1b.	Re-election of Director: Cynthia L. Feldmann	Management	For	For
1c.	Re-election of Director: Dr. Jacqueline B. Kosecoff	Management	For	For
1d.	Re-election of Director: David B. Lewis	Management	For	For
1e.	Re-election of Director: Walter M Rosebrough, Jr.	Management	For	For
1f.	Re-election of Director: Dr. Nirav R. Shah	Management	For	For
1g.	Re-election of Director: Dr. Mohsen M. Sohi	Management	For	For
1h.	Re-election of Director: Dr. Richard M. Steeves	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2021.	Management	For	For
3.	To appoint Ernst & Young Chartered Accountants as the Company's Irish statutory auditor under the Act to hold office until the conclusion of the Company's next Annual General Meeting.	Management	For	For
4.	To authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company's Irish statutory auditor.	Management	For	For
5.	To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2020.	Management	For	For

STRYKER CORPORATION
Security	863667101	Meeting Type	Annual
Ticker Symbol	SYK	Meeting Date	05-May-2020
Record Date	06-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Mary K. Brainerd	Management	For	For
1B.	Election of Director: Srikant M. Datar, Ph.D.	Management	For	For
1C.	Election of Director: Roch Doliveux, DVM	Management	For	For
1D.	Election of Director: Allan C. Golston(Lead Independent Director)	Management	For	For
1E.	Election of Director: Kevin A. Lobo(Chairman of the Board)	Management	For	For
1F.	Election of Director: Sherilyn S. McCoy	Management	For	For
1G.	Election of Director: Andrew K. Silvernail	Management	For	For
1H.	Election of Director: Lisa M. Skeete Tatum	Management	For	For
1I.	Election of Director: Ronda E. Stryker	Management	For	For
1J.	Election of Director: Rajeev Suri	Management	For	For
2.	Ratify appointment of Ernst & Young LLP as our independent registered public accounting firm for 2020.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	Non-management employee representation on the Board of Directors.	Management	Against	For

SYSMEX CORPORATION
Security	J7864H102	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	19-Jun-2020
Record Date	31-Mar-2020

 

Item	Proposal	Proposed by	Vote	For/Against Management
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director who is not Audit and Supervisory Committee Member Ietsugu, Hisashi	Management	For	For
2.2	Appoint a Director who is not Audit and Supervisory Committee Member Nakajima, Yukio	Management	For	For
2.3	Appoint a Director who is not Audit and Supervisory Committee Member Asano, Kaoru	Management	For	For
2.4	Appoint a Director who is not Audit and Supervisory Committee Member Tachibana, Kenji	Management	For	For
2.5	Appoint a Director who is not Audit and Supervisory Committee Member Yamamoto, Junzo	Management	For	For
2.6	Appoint a Director who is not Audit and Supervisory Committee Member Matsui, Iwane	Management	For	For
2.7	Appoint a Director who is not Audit and Supervisory Committee Member Kanda, Hiroshi	Management	For	For
2.8	Appoint a Director who is not Audit and Supervisory Committee Member Takahashi, Masayo	Management	For	For
2.9	Appoint a Director who is not Audit and Supervisory Committee Member Ota, Kazuo	Management	For	For
3.1	Appoint a Director who is Audit and Supervisory Committee Member Kamao, Yukitoshi	Management	For	For
3.2	Appoint a Director who is Audit and Supervisory Committee Member Hashimoto, Kazumasa	Management	For	For
3.3	Appoint a Director who is Audit and Supervisory Committee Member Iwasa, Michihide	Management	For	For

TAKEDA PHARMACEUTICAL CO LTD
Security	874060205	Meeting Type	Annual
Ticker Symbol	TAK	Meeting Date	24-Jun-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Appropriation of Surplus	Management	For
2a.	Election of Director who is not an Audit and Supervisory Committee Member: Christophe Weber	Management	For
2b.	Election of Director who is not an Audit and Supervisory Committee Member: Masato Iwasaki	Management	For
2c.	Election of Director who is not an Audit and Supervisory Committee Member: Andrew Plump	Management	For
2d.	Election of Director who is not an Audit and Supervisory Committee Member: Costa Saroukos	Management	For
2e.	Election of Director who is not an Audit and Supervisory Committee Member: Masahiro Sakane	Management	For
2f.	Election of Director who is not an Audit and Supervisory Committee Member: Oliver Bohuon	Management	For
2g.	Election of Director who is not an Audit and Supervisory Committee Member: Jean-Luc Butel	Management	For
2h.	Election of Director who is not an Audit and Supervisory Committee Member: Ian Clark	Management	For
2i.	Election of Director who is not an Audit and Supervisory Committee Member: Yoshiaki Fujimori	Management	For
2j.	Election of Director who is not an Audit and Supervisory Committee Member: Steven Gillis	Management	For
2k.	Election of Director who is not an Audit and Supervisory Committee Member: Shiro Kuniya	Management	For
2l.	Election of Director who is not an Audit and Supervisory Committee Member: Toshiyuki Shiga	Management	For
3a.	Election of Director who is Audit and Supervisory Committee Member: Yasuhiko Yamanaka	Management	For
3b.	Election of Director who is Audit and Supervisory Committee Member: Koji Hatsukawa	Management	For
3c.	Election of Director who is Audit and Supervisory Committee Member: Emiko Higashi	Management	For
3d.	Election of Director who is Audit and Supervisory Committee Member: Michel Orsinger	Management	For
4.	Payment of Bonuses to Directors who are not Audit and Supervisory Committee Members	Management	For
5.	Election of Director who is an Audit and Supervisory Committee Member: Takeshi Ito	Management	Against

TELEFLEX INCORPORATED
Security	879369106	Meeting Type	Annual
Ticker Symbol	TFX	Meeting Date	01-May-2020
Record Date	02-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: George Babich, Jr.	Management	For	For
1B.	Election of Director: Gretchen R. Haggerty	Management	For	For
1C.	Election of Director: Liam J. Kelly	Management	For	For
2.	Approval, on an advisory basis, of named executive officer compensation.	Management	For	For
3.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2020.	Management	For	For

TERUMO CORPORATION
Security	J83173104	Meeting Type	Annual General Meeting
Ticker Symbol	N/A	Meeting Date	25-Jun-2020
Record Date	31-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1	Approve Appropriation of Surplus	Management	For	For
2.1	Appoint a Director who is not Audit and Supervisory Committee Member Mimura, Takayoshi	Management	For	For
2.2	Appoint a Director who is not Audit and Supervisory Committee Member Sato, Shinjiro	Management	For	For
2.3	Appoint a Director who is not Audit and Supervisory Committee Member Takagi, Toshiaki	Management	For	For
2.4	Appoint a Director who is not Audit and Supervisory Committee Member Hatano, Shoji	Management	For	For
2.5	Appoint a Director who is not Audit and Supervisory Committee Member Nishikawa, Kyo	Management	For	For
2.6	Appoint a Director who is not Audit and Supervisory Committee Member Ueda, Ryuzo	Management	For	For
2.7	Appoint a Director who is not Audit and Supervisory Committee Member Kuroda, Yukiko	Management	For	For
2.8	Appoint a Director who is not Audit and Supervisory Committee Member Nishi, Hidenori	Management	For	For
3	Appoint a Substitute Director who is Audit and Supervisory Committee Member Sakaguchi, Koichi	Management	For	For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Security	881624209	Meeting Type	Annual
Ticker Symbol	TEVA	Meeting Date	09-Jun-2020
Record Date	09-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Dr. Sol J. Barer	Management	For	For
1B.	Election of Director: Jean-Michel Halfon	Management	For	For
1C.	Election of Director: Nechemia (Chemi) J. Peres	Management	For	For
1D.	Election of Director: Janet S. Vergis	Management	For	For
2.	To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.	Management	For	For
3.	To approve Teva's 2020 Long-Term Equity-Based Incentive Plan, substantially in the form attached as Appendix A to the Proxy Statement.	Management	For	For
4.	To approve an amendment to the terms of office and employment of Teva's President and Chief Executive Officer.	Management	For	For
5.	To approve an amendment to Teva's Articles of Association.	Management	For	For
6.	To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2021 annual meeting of shareholders.	Management	For	For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Security	881624209	Meeting Type	Annual
Ticker Symbol	TEVA	Meeting Date	09-Jun-2020
Record Date	30-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Dr. Sol J. Barer	Management	For	For
1B.	Election of Director: Jean-Michel Halfon	Management	For	For
1C.	Election of Director: Nechemia (Chemi) J. Peres	Management	For	For
1D.	Election of Director: Janet S. Vergis	Management	For	For
2.	To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.	Management	For	For
3.	To approve Teva's 2020 Long-Term Equity-Based Incentive Plan, substantially in the form attached as Appendix A to the Proxy Statement.	Management	For	For
4.	To approve an amendment to the terms of office and employment of Teva's President and Chief Executive Officer.	Management	For	For
5.	To approve an amendment to Teva's Articles of Association.	Management	For	For
6.	To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2021 annual meeting of shareholders.	Management	For	For

THERMO FISHER SCIENTIFIC INC.
Security	883556102	Meeting Type	Annual
Ticker Symbol	TMO	Meeting Date	20-May-2020
Record Date	27-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Marc N. Casper	Management	For	For
1B.	Election of Director: Nelson J. Chai	Management	For	For
1C.	Election of Director: C. Martin Harris	Management	For	For
1D.	Election of Director: Tyler Jacks	Management	For	For
1E.	Election of Director: Judy C. Lewent	Management	For	For
1F.	Election of Director: Thomas J. Lynch	Management	For	For
1G.	Election of Director: Jim P. Manzi	Management	For	For
1H.	Election of Director: James C. Mullen	Management	For	For
1I.	Election of Director: Lars R. Sørensen	Management	For	For
1J.	Election of Director: Debora L. Spar	Management	For	For
1K.	Election of Director: Scott M. Sperling	Management	For	For
1L.	Election of Director: Dion J. Weisler	Management	For	For
2.	An advisory vote to approve named executive officer compensation.	Management	For	For
3.	Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2020.	Management	For	For

UNITEDHEALTH GROUP INCORPORATED
Security	91324P102	Meeting Type	Annual
Ticker Symbol	UNH	Meeting Date	01-Jun-2020
Record Date	07-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Richard T. Burke	Management	For	For
1B.	Election of Director: Timothy P. Flynn	Management	For	For
1C.	Election of Director: Stephen J. Hemsley	Management	For	For
1D.	Election of Director: Michele J. Hooper	Management	For	For
1E.	Election of Director: F. William McNabb III	Management	For	For
1F.	Election of Director: Valerie C. Montgomery Rice, M.D.	Management	For	For
1G.	Election of Director: John H. Noseworthy, M.D.	Management	For	For
1H.	Election of Director: Glenn M. Renwick	Management	For	For
1I.	Election of Director: David S. Wichmann	Management	For	For
1J.	Election of Director: Gail R. Wilensky, Ph.D.	Management	For	For
2.	Advisory approval of the Company's executive compensation.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2020.	Management	For	For
4.	Approval of the UnitedHealth Group 2020 Stock Incentive Plan.	Management	For	For
5.	If properly presented at the 2020 Annual Meeting of Shareholders, the shareholder proposal set forth in the proxy statement requesting any material amendment to the Company's Bylaws be subject to a non-binding shareholder vote.	Shareholder	Against	For

UNIVERSAL HEALTH REALTY INCOME TRUST
Security	91359E105	Meeting Type	Annual
Ticker Symbol	UHT	Meeting Date	03-Jun-2020
Record Date	06-Apr-2020

Item		Proposal			Proposed by	Vote	For/Against Management
1.		DIRECTOR			Management
			1	Alan B. Miller		For	For
			2	Robert F. McCadden		For	For
2.	Advisory (nonbinding) vote to approve named executive officer compensation.				Management	For	For
3.	To approve an amendment to the Universal Health Realty Income Trust Amended and Restated 2007 Restricted Stock Plan.				Management	For	For
4.	To ratify the selection of KPMG LLP, as the Trust's independent registered public accounting firm for the fiscal year ending December 31, 2020.				Management	For	For

VENTAS, INC.
Security	92276F100	Meeting Type	Annual
Ticker Symbol	VTR	Meeting Date	18-May-2020
Record Date	20-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval, on an advisory basis, of our executive compensation.	Management	For	For
2A.	Election of Director: Melody C. Barnes	Management	For	For
2B.	Election of Director: Debra A. Cafaro	Management	For	For
2C.	Election of Director: Jay M. Gellert	Management	For	For
2D.	Election of Director: Richard I. Gilchrist	Management	For	For
2E.	Election of Director: Matthew J. Lustig	Management	For	For
2F.	Election of Director: Roxanne M. Martino	Management	For	For
2G.	Election of Director: Sean P. Nolan	Management	For	For
2H.	Election of Director: Walter C. Rakowich	Management	For	For
2I.	Election of Director: Robert D. Reed	Management	For	For
2J.	Election of Director: James D. Shelton	Management	For	For
3.	Ratification of the selection of KPMG LLP as the independent registered public accounting firm for fiscal year 2020.	Management	For	For

VERONA PHARMA PLC
Security	925050106	Meeting Type	Annual
Ticker Symbol	VRNA	Meeting Date	16-Apr-2020
Record Date	13-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
O1.	To receive and adopt the report of the directors and the financial statements for the year ended 31 December 2019.	Management	For	For
O2.	To approve the Directors' Remuneration Report.	Management	For	For
O3.	To re-elect Mr Rishi Gupta as a director of the Company.	Management	For	For
O4.	To re-elect Dr Mahendra Shah as a director of the Company.	Management	For	For
O5.	To re-elect Mr Vikas Sinha as a director of the Company.	Management	For	For
O6.	To re-elect Dr David Zaccardelli as a director of the Company.	Management	For	For
O7.	To appoint PricewaterhouseCoopers LLP as auditors.	Management	For	For
O8.	To authorise the directors to determine the auditors' remuneration.	Management	For	For
O9.	To approve amendments to the Verona Pharma plc 2017 Incentive Award Plan - Increase overall share limits.	Management	For	For
O10.	To approve amendments to the Verona Pharma plc 2017 Incentive Award Plan - Extend the term of the Plan until 29th April 2030.	Management	For	For
O11.	To authorise the directors to allot relevant securities pursuant to Section 551 of the Companies Act 2006.	Management	For	For
S12.	To authorise the directors to allot equity securities pursuant to Section 570 of the Companies Act 2006.	Management	For	For

VERONA PHARMA PLC
Security	G9337X139	Meeting Type	Annual General Meeting
Ticker Symbol		Meeting Date	16-Apr-2020
Record Date

Item	Proposal	Proposed by	Vote	For/Against Management
1.	TO RECEIVE AND ADOPT THE REPORT OF THE DIRECTORS AND THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2019 AND THE REPORT OF THE AUDITORS THEREON (THE "ANNUAL REPORT")	Management	For	For
2.	TO APPROVE THE DIRECTORS' REMUNERATION REPORT AS SET OUT ON PAGES 33 TO 52 OF THE ANNUAL REPORT	Management	For	For
3.	TO RE-ELECT, AS A DIRECTOR OF THE COMPANY, RISHI GUPTA, WHO RETIRES IN ACCORDANCE WITH ARTICLE 26.2 OF THE COMPANY'S ARTICLES OF ASSOCIATION AND OFFERS HIMSELF FOR RE- ELECTION	Management	For	For
4.	TO RE-ELECT, AS A DIRECTOR OF THE COMPANY, MAHENDRA SHAH, WHO RETIRES IN ACCORDANCE WITH ARTICLE 26.2 OF THE COMPANY'S ARTICLES OF ASSOCIATION AND OFFERS HIMSELF FOR RE- ELECTION	Management	For	For
5.	TO RE-ELECT, AS A DIRECTOR OF THE COMPANY, VIKAS SINHA, WHO RETIRES IN ACCORDANCE WITH ARTICLE 26.2 OF THE COMPANY'S ARTICLES OF ASSOCIATION AND OFFERS HIMSELF FOR RE- ELECTION	Management	For	For
6.	TO RE-ELECT, AS A DIRECTOR OF THE COMPANY, DAVID ZACCARDELLI, WHO RETIRES IN ACCORDANCE WITH ARTICLE 21.2 OF THE COMPANY'S ARTICLES OF ASSOCIATION AND OFFERS HIMSELF FOR RE-ELECTION	Management	For	For
7.	TO RE-APPOINT PRICEWATERHOUSECOOPERS LLP AS THE COMPANY'S AUDITOR TO HOLD OFFICE UNTIL THE CONCLUSION OF THE NEXT GENERAL MEETING AT WHICH ACCOUNTS ARE LAID BEFORE THE COMPANY	Management	For	For
8.	TO AUTHORISE THE DIRECTORS TO DETERMINE THE AUDITOR'S REMUNERATION	Management	For	For
9.	AMENDMENTS TO THE VERONA PHARMA PLC 2017 INCENTIVE AWARD PLAN	Management	For	For
10.	TO APPROVE AN AMENDMENT TO THE 2017 PLAN IN ACCORDANCE WITH THE APPROVAL OF SUCH AMENDMENT BY THE DIRECTORS AND THE DIRECTION THAT SUCH AMENDMENT BE SUBMITTED TO THE SHAREHOLDERS OF THE COMPANY FOR APPROVAL, TO EXTEND THE TERM OF THE 2017 PLAN TO APRIL 29, 2030 BY AMENDING AND RESTATING IN ITS ENTIRETY THE FIRST SENTENCE OF SECTION 10.3 OF THE 2017 PLAN TO READ AS FOLLOWS: "THE PLAN BECAME EFFECTIVE ON APRIL 26, 2017 AND, UNLESS EARLIER TERMINATED BY THE BOARD, WILL REMAIN IN EFFECT UNTIL APRIL 29, 2030, BUT AWARDS PREVIOUSLY GRANTED MAY EXTEND BEYOND THAT DATE IN ACCORDANCE WITH THE PLAN."	Management	For	For
11.	AUTHORITY TO ALLOT SHARES	Management	For	For
12.	DISAPPLICATION OF PRE-EMPTION RIGHTS	Management	For	For

VERTEX PHARMACEUTICALS INCORPORATED
Security	92532F100	Meeting Type	Annual
Ticker Symbol	VRTX	Meeting Date	03-Jun-2020
Record Date	09-Apr-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Sangeeta Bhatia	Management	For	For
1B.	Election of Director: Lloyd Carney	Management	For	For
1C.	Election of Director: Alan Garber	Management	For	For
1D.	Election of Director: Terrence Kearney	Management	For	For
1E.	Election of Director: Reshma Kewalramani	Management	For	For
1F.	Election of Director: Yuchun Lee	Management	For	For
1G.	Election of Director: Jeffrey Leiden	Management	For	For
1H.	Election of Director: Margaret McGlynn	Management	For	For
1I.	Election of Director: Diana McKenzie	Management	For	For
1J.	Election of Director: Bruce Sachs	Management	For	For
2.	Ratification of Ernst & Young LLP as our independent Registered Public Accounting firm for the year ending December 31, 2020.	Management	For	For
3.	Advisory vote on named executive officer compensation.	Management	For	For
4.	Shareholder proposal, if properly presented at the meeting, requesting that we prepare a report on our policies and activities with respect to lobbying.	Shareholder	Against	For

WATERS CORPORATION
Security	941848103	Meeting Type	Annual
Ticker Symbol	WAT	Meeting Date	12-May-2020
Record Date	18-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Linda Baddour	Management	For	For
1B.	Election of Director: Michael J Berendt, PH.D	Management	For	For
1C.	Election of Director: Edward Conard	Management	For	For
1D.	Election of Director: Laurie H. Glimcher, M.D	Management	For	For
1E.	Election of Director: Gary E. Hendrickson	Management	For	For
1F.	Election of Director: Christopher A. Kuebler	Management	For	For
1G.	Election of Director: Christopher J O'Connell	Management	For	For
1H.	Election of Director: Flemming Ornskov, M.D., M.P.H	Management	For	For
1I.	Election of Director: JoAnn A. Reed	Management	For	For
1J.	Election of Director: Thomas P. Salice	Management	For	For
2.	To ratify the selection of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2020.	Management	For	For
3.	To approve, by non-binding vote, named executive officer compensation.	Management	For	For
4.	To approve the 2020 Equity Incentive Plan.	Management	For	For

WELLTOWER INC.
Security	95040Q104	Meeting Type	Annual
Ticker Symbol	WELL	Meeting Date	30-Apr-2020
Record Date	03-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kenneth J. Bacon	Management	For	For
1B.	Election of Director: Thomas J. DeRosa	Management	For	For
1C.	Election of Director: Karen B. DeSalvo	Management	For	For
1D.	Election of Director: Jeffrey H. Donahue	Management	For	For
1E.	Election of Director: Sharon M. Oster	Management	For	For
1F.	Election of Director: Sergio D. Rivera	Management	For	For
1G.	Election of Director: Johnese M. Spisso	Management	For	For
1H.	Election of Director: Kathryn M. Sullivan	Management	For	For
2.	The ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year 2020.	Management	For	For
3.	The approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the 2020 Proxy Statement.	Management	For	For

ZIMMER BIOMET HOLDINGS, INC.
Security	98956P102	Meeting Type	Annual
Ticker Symbol	ZBH	Meeting Date	08-May-2020
Record Date	09-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Christopher B. Begley	Management	For	For
1B.	Election of Director: Betsy J. Bernard	Management	For	For
1C.	Election of Director: Gail K. Boudreaux	Management	For	For
1D.	Election of Director: Michael J. Farrell	Management	For	For
1E.	Election of Director: Larry C. Glasscock	Management	For	For
1F.	Election of Director: Robert A. Hagemann	Management	For	For
1G.	Election of Director: Bryan C. Hanson	Management	For	For
1H.	Election of Director: Arthur J. Higgins	Management	For	For
1I.	Election of Director: Maria Teresa Hilado	Management	For	For
1J.	Election of Director: Syed Jafry	Management	For	For
1K.	Election of Director: Michael W. Michelson	Management	For	For
2.	Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2020.	Management	For	For
3.	Advisory vote to approve named executive officer compensation (Say on Pay).	Management	For	For

ZOETIS INC.
Security	98978V103	Meeting Type	Annual
Ticker Symbol	ZTS	Meeting Date	20-May-2020
Record Date	26-Mar-2020

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Gregory Norden	Management	For	For
1B.	Election of Director: Louise M. Parent	Management	For	For
1C.	Election of Director: Kristin C. Peck	Management	For	For
1D.	Election of Director: Robert W. Scully	Management	For	For
2.	Advisory vote to approve our executive compensation (Say on Pay).	Management	For	For
3.	Advisory vote on the frequency of future advisory votes on executive compensation (Say on Pay frequency).	Management	1 Year	For
4.	Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2020.	Management	For	For

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)		Tekla World Healthcare Fund
By (Signature and Title)*
			/s/ Daniel R. Omstead
			(Daniel R. Omstead, President)
Date	8/17/20

*Print the name and title of each signing officer under his or her signature.